Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1050.Time spend outdoors in summer,44884,0.0365473868770652,0.0486724194897351,-0.0588505553228156,0.131945329076946,0.452730307899201
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1060.Time spent outdoors in winter,41745,0.00489030679736597,0.0564633144999474,-0.105777789622531,0.115558403217263,0.930982217242645
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1070.Time spent watching television (TV),45893,-0.0657628556469558,0.0483020513568505,-0.160434876306383,0.0289091650124711,0.173372188235611
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1080.Time spent using computer,41726,0.057428694295758,0.0528173948075004,-0.0460933995269428,0.160950788118459,0.276916066088711
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1090.Time spent driving,40786,-0.0299739588330336,0.0553162997445757,-0.138393906332402,0.0784459886663348,0.587918741430443
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1160.Sleep duration,47394,-0.0102094280687481,0.0458018258248906,-0.0999810066855337,0.0795621505480374,0.823611853831411
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32386,-0.00526722522410317,0.0094653343526487,-0.0238192805552946,0.0132848301070883,0.577900547232546
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32386,-0.00761364793272866,0.00931112591831906,-0.025863454732634,0.0106361588671767,0.413555024211141
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32386,0.00681229347772947,0.0108396077488049,-0.0144333377099282,0.0280579246653871,0.529717447423428
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32386,0.000147595317663918,0.0111540508016154,-0.0217143442535022,0.0220095348888301,0.989442657438011
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32386,0.0030081142690607,0.0114106521263602,-0.0193567638986053,0.0253729924367267,0.792076539769178
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32386,-0.00980842373985133,0.0219100037183929,-0.0527520310279014,0.0331351835481988,0.654403659368912
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32386,-0.0138267400229066,0.0223965055791735,-0.0577238909580866,0.0300704109122734,0.537012804744071
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32386,-0.00290178518207364,0.0159997342851587,-0.0342612643809846,0.0284576940168373,0.856085725438325
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32386,-0.0021238956321715,0.0120529150185644,-0.0257476090685577,0.0214998178042147,0.860129794774429
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32386,-0.00844204977800653,0.0084021160514573,-0.0249101972388628,0.00802609768284977,0.315044402321977
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32386,-0.00607548373453472,0.0117912138646581,-0.0291862629092646,0.0170352954401952,0.606388089815436
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32386,-0.00556923802046065,0.00682138111324386,-0.0189391450024186,0.00780066896149732,0.414272206563563
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32386,-0.00151788361290463,0.00875914282977345,-0.0186858035592606,0.0156500363334513,0.862426542789566
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32386,0.00611790989237745,0.0131776318818916,-0.01971024859613,0.0319460683808849,0.642469933839128
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32386,-0.0088316538098303,0.0123247998073268,-0.0329882614321907,0.0153249538125301,0.473655482021312
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32386,0.0100619063526469,0.0150384415739632,-0.0194134391323209,0.0395372518376147,0.503463162787223
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32386,-0.00790812306021348,0.0146384238472488,-0.0365994338008212,0.0207831876803943,0.589052190527928
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32386,-0.00171120572461081,0.00972116596366021,-0.0207646910133848,0.0173422795641632,0.860275453086327
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32386,0.0119333454842704,0.0091525970283576,-0.00600574469131054,0.0298724356598512,0.192329923389599
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32386,-0.00719498790404619,0.0113602442309053,-0.0294610665966207,0.0150710907885283,0.526523405804185
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120040.Fatigue severity over the past week,32394,-0.049294403148336,0.0783273026408223,-0.202815916324348,0.104227110027676,0.529144187901574
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120041.Waking unrefreshed severity over the past week,32396,-0.0444587191140504,0.0775809138520366,-0.196517310264042,0.107599872035941,0.566617417280151
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120042.Cognitive symptoms severity over the past week,32394,0.00762693571828324,0.0836194676747066,-0.156267220924142,0.171521092360708,0.927327831734871
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120098.Mobility problems today,32398,-0.0494395481419796,0.0947231236979869,-0.235096870590034,0.136217774306075,0.601727408377957
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120099.Self-care problems today,32398,-0.137526270351595,0.150762323617714,-0.433020424642315,0.157967883939125,0.361686140524056
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120100.Problems doing usual activities,32398,0.0463922129939863,0.0891665157988276,-0.128374157971716,0.221158583959688,0.602876784684753
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120101.Pain or discomfort today,32398,-0.0671691611787606,0.0778746445713462,-0.219803464538599,0.085465142181078,0.388420561414191
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120102.Anxiety or depression today,32398,-0.0743612366968489,0.0932468985706986,-0.257125157895418,0.10840268450172,0.425202592078479
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120103.Scale to indicate how health is today,32369,0.00163790599544218,0.00293388469146443,-0.0041125079998281,0.00738831999071245,0.576673275888743
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32382,-0.0988415514486949,0.0939822976970265,-0.283046854934867,0.085363752037477,0.292965236536631
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32369,-0.135882646327437,0.0965309143687894,-0.325083238490264,0.0533179458353905,0.159268495669105
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32388,-0.00621137953901599,0.0782249565649364,-0.159532294406291,0.147109535328259,0.936713098926274
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32390,-0.0874738818188825,0.0799620727383116,-0.244199544385973,0.0692517807482083,0.274011248259674
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32385,0.00430214544552021,0.0974076078190584,-0.186616765879834,0.195221056770875,0.964772782493268
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120109.Feeling bad about self over the last two weeks,32364,0.0332012778705461,0.098979422246926,-0.160798389733429,0.227200945474521,0.737304366699726
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120110.Trouble concentrating over the last two weeks,32391,-0.0711983229056006,0.0996178590543098,-0.266449326652048,0.124052680840847,0.474805070866789
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32378,-0.139443450797493,0.152047677677133,-0.437456899044674,0.158569997449688,0.359114400614842
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32334,-0.167181331604063,0.201153134971911,-0.561441476149009,0.227078812940882,0.405932246705217
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",29949,0.0318507979982997,0.10398607341487,-0.171961905894846,0.235663501891445,0.759387712787458
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1269.Exposure to tobacco smoke at home,44755,-0.00780688470538499,0.108779413383795,-0.221014534937623,0.205400765526853,0.942787198789475
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43642,-0.0370095584437568,0.0661211134461327,-0.166606940798177,0.0925878239106633,0.575674208791746
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1289.Cooked vegetable intake,46527,-0.0611435692938512,0.0472880179454245,-0.153828084466883,0.0315409458791809,0.19602305232093
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46093,0.0082318533721978,0.0507468748896082,-0.0912320214114342,0.10769572815583,0.871138812562207
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1309.Fresh fruit intake,46505,0.00793084042955408,0.050640567752852,-0.0913246723660359,0.107186353225144,0.875553288515584
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1319.Dried fruit intake,45240,-0.0142324346608741,0.053090730855371,-0.118290267137401,0.0898253978156529,0.788642189131092
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X134.Number of self-reported cancers,47590,0.0757151887542485,0.102639040629514,-0.1254573308796,0.276887708388097,0.460713728905594
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X135.Number of self-reported non-cancer illnesses,47590,-0.0142139510519386,0.0458721424794832,-0.104123350311726,0.0756954482078485,0.756669994131545
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X136.Number of operations, self-reported",47590,-0.0279483233959791,0.0457044712455265,-0.117529087037211,0.0616324402452528,0.540873908456882
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X137.Number of treatments or medications taken,47590,-0.0247322598446806,0.0458329725506214,-0.114564886043899,0.0651003663545373,0.589466122857577
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1438.Bread intake,46853,5.83814017270496e-05,0.00182226886281858,-0.00351326556939738,0.00363002837285147,0.97444222100242
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1458.Cereal intake,46183,0.0138863405668172,0.0473546079364144,-0.0789286909885549,0.106701372122189,0.76934022170795
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1488.Tea intake,46653,-0.00013584091087521,0.00172829843664261,-0.00352330584669473,0.00325162402494431,0.937353017555763
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1498.Coffee intake,45638,0.0440103249961533,0.0478172942944585,-0.0497115718209855,0.137732221813292,0.357381749410441
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1528.Water intake,45921,0.0707798462773995,0.0489683825413023,-0.025198183503553,0.166757876058352,0.148354344487902
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1568.Average weekly red wine intake,39930,0.0481696385628761,0.0565925338646227,-0.0627517278117845,0.159091004937537,0.394689851044574
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,39927,-0.0210148094926298,0.0581174379811301,-0.134924987935645,0.0928953689503851,0.717661585001803
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1588.Average weekly beer plus cider intake,39969,-0.15698424573728,0.0641735234402614,-0.282764351680192,-0.0312041397943673,0.014445852807121
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1598.Average weekly spirits intake,39904,0.101529849073382,0.0629307865708476,-0.0218144926054798,0.224874190752243,0.106686554489501
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1608.Average weekly fortified wine intake,39957,0.030957153463919,0.115066473077088,-0.194573133767174,0.256487440695012,0.78790455975832
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1737.Childhood sunburn occasions,42086,-0.0630302319530393,0.0543031932159087,-0.16946449065622,0.0434040267501418,0.245775262649181
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1807.Father's age at death,38058,0.000723887671561451,0.00236591839042486,-0.00391331237367128,0.00536108771679418,0.759635957148653
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1845.Mother's age,37376,0.000778038186728029,0.00374386523298819,-0.00655993766992881,0.00811601404338487,0.835375125868824
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1873.Number of full brothers,47169,0.014411375836069,0.0461021711606953,-0.0759488796388939,0.104771631311032,0.754590059049369
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1883.Number of full sisters,47168,-0.0025255498830264,0.0459754704537679,-0.0926374719724115,0.0875863722063588,0.956192669783648
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20015.Sitting height,47389,0.00190098684527535,0.00230067302252507,-0.00260833227887378,0.00641030596942448,0.40865692306725
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20016.Fluid intelligence score,31422,0.142339986290149,0.0768244584816391,-0.00823595233386396,0.292915924914161,0.0639507175063945
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20018.Prospective memory result,31722,-0.31541981414897,0.110854624066482,-0.532694877319274,-0.0981447509786655,0.00444778589499811
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),31358,0.00603101846551878,0.00317187247140636,-0.000185851578437693,0.0122478885094753,0.0572871053263035
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),31363,0.0023806957600814,0.0031525544540537,-0.00379831096986385,0.00855970249002664,0.450174265478649
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20023.Mean time to correctly identify matches,47320,0.000814774085561597,0.00182419624700172,-0.00276065055856178,0.00439019872968497,0.655133165303852
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#1.Illnesses of father_Heart disease,44852,-0.00307459905275334,0.00395724024403308,-0.0108307899310582,0.0046815918255515,0.437193857478592
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44485,0.00610849710539956,0.00908449616105914,-0.0116971153702764,0.0239141095810755,0.501330878507089
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44458,-0.0101597406423915,0.0120956635503729,-0.0338672412011224,0.0135477599163395,0.400946724720504
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#12.Illnesses of father_Severe depression,44486,0.00355627491491869,0.00921678322405398,-0.0145086202042271,0.0216211700340645,0.699613420916671
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44488,0.0197232939109364,0.00675920990874705,0.00647524248979214,0.0329713453320806,0.00352678086822456
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#2.Illnesses of father_Stroke,44623,0.00164026211432485,0.00521084375011119,-0.00857299163589308,0.0118535158645428,0.752932922136105
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44573,0.0101843114978465,0.00683413769734664,-0.00321059838895296,0.0235792213846459,0.136183825433853
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44488,-0.00506255579549545,0.00819993619686634,-0.0211344307413535,0.0110093191503626,0.536984557386962
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44600,-0.000648132889700849,0.00645311811605284,-0.0132962443971644,0.0119999786177627,0.91999823623873
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44721,0.000125694478586643,0.00410953067260591,-0.00792898563972095,0.00818037459689423,0.975599927435186
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#9.Illnesses of father_Diabetes,44596,0.00305329877418582,0.00557545035054783,-0.00787458391288794,0.0139811814612596,0.583950044880745
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#1.Illnesses of mother_Heart disease,45728,0.000702558442875206,0.0047415041757928,-0.00859078974167868,0.0099959066274291,0.882208347163183
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,45626,-0.0038565717521597,0.00768436034367277,-0.0189179180257583,0.0112047745214389,0.615762047590711
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45574,-0.0258167237882995,0.0165961491334175,-0.0583451760897978,0.00671172851319873,0.119821336728837
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#12.Illnesses of mother_Severe depression,45613,0.00513693788432443,0.00690745401000144,-0.00840167197527838,0.0186755477439272,0.457077906280199
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#2.Illnesses of mother_Stroke,45678,0.00225344071556848,0.00564226739836281,-0.00880540338522262,0.0133122848163596,0.68961296424765
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,45620,-0.000905721833963063,0.009226936888811,-0.0189905181360326,0.0171790744681065,0.921805657221019
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,45599,-0.00108082317035306,0.00870290208483616,-0.0181385112566319,0.0159768649159258,0.901165100045529
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,45626,0.00117514546138376,0.0066066129784462,-0.0117738159763708,0.0141241068991383,0.858823492221201
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,45635,6.69402377267127e-05,0.00776199133120356,-0.0151465627714323,0.0152804432468857,0.993119123095179
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,45824,0.00153671937518411,0.00372953047227105,-0.00577316035046715,0.00884659910083537,0.68031341089551
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#9.Illnesses of mother_Diabetes,45681,-0.00107475745122169,0.00577735679841213,-0.0123983767761095,0.0102488618736661,0.852423539254747
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43329,-0.000488249295030085,0.00764376958443193,-0.0154700376805167,0.0144935390904565,0.949070048561491
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43237,0.0829098558573263,0.0454736648495445,-0.00621852724778099,0.172038238962434,0.0682809466392951
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43236,-0.0364446152755155,0.0357878432756373,-0.106588788095765,0.0336995575447335,0.308523505891141
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43309,0.00488667679041471,0.00705544698252375,-0.00894199929533184,0.0187153528761613,0.488562277195618
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43240,0.0226783708616222,0.0240825338902419,-0.0245233955632518,0.0698801372864963,0.346361210459738
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43255,0.00188115351724153,0.0131349886553142,-0.0238634242471743,0.0276257312816573,0.886120301167773
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43241,0.048552865854068,0.0173039460176721,0.0146371316594307,0.0824686000487052,0.00502287683358402
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43252,0.0116193644272929,0.0157118764718914,-0.0191759134576143,0.0424146423122,0.459595710751144
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43252,0.00439885072486623,0.0105086042146493,-0.0161980135358463,0.0249957149855788,0.67551667273512
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43258,-0.0161223809541057,0.0139382414857764,-0.0434413342662275,0.0111965723580161,0.247408694714007
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43409,-0.00601713342696265,0.00492063496854578,-0.0156615779653124,0.00362731111138708,0.221406091514253
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43317,-0.0140186286324351,0.00718477707948896,-0.0281007917082335,6.35344433632112e-05,0.0510526951161119
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20127.Neuroticism score,42855,0.016358157576937,0.0477853816011039,-0.0773011903612268,0.110017505515101,0.732109690945307
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,31422,0.0695897401548051,0.0783039190392783,-0.0838859411621804,0.223065421471791,0.374185450229
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X20161.Pack years of smoking,30508,-0.00343347735778868,0.00371822947958308,-0.0107212071377715,0.00385425242219416,0.355823302408198
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30508,-0.00305212888894372,0.003475311040028,-0.00986373852739859,0.00375948074951116,0.379849642624114
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20191.Fluid intelligence score,29932,-0.0178525112932728,0.0847677045530947,-0.183997212217338,0.148292189630793,0.833202509494551
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,29932,-0.0649218157070286,0.0852756912185732,-0.232062170495432,0.102218539081375,0.446497497241779
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20240.Maximum digits remembered correctly,29390,-0.0983686949564518,0.0924031427872661,-0.279478854819493,0.0827414649065897,0.287121610348111
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20255.Spirometry QC measure,41468,-0.0870378489630668,0.061098654118617,-0.206791211035556,0.0327155131094226,0.154306172824657
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X20261.avMSE,29043,-0.00390849446068177,0.00392159595824869,-0.0115948225388492,0.00377783361748566,0.318976515513352
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X20262.Myopia diagnosis,29043,0.112940113353346,0.113722013160982,-0.109955032442179,0.33583525914887,0.3206956734568
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X20280.Glucose-lactate,36932,0.00434411640383103,0.00238246009256769,-0.00032550537760165,0.00901373818526371,0.0682695521100974
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X20281.Spectrometer-corrected alanine,36958,-4.9557122007865e-05,0.00234886489160608,-0.00465333230955579,0.00455421806554006,0.983167540006424
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31238,0.00457425556290215,0.0116072389230432,-0.0181759327262625,0.0273244438520668,0.693528605044519
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31236,-0.0154431439932648,0.0233439749160717,-0.0611973348287653,0.0303110468422358,0.508282044642564
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31236,0.0193942829094034,0.0260685652166782,-0.031700104915286,0.0704886707340927,0.456917106251942
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31236,0.00828406005707016,0.0112043836057933,-0.0136765318102848,0.0302446519244251,0.459712657569252
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31236,-0.00178066661874498,0.0176590525616371,-0.0363924096395536,0.0328310764020636,0.919683461416525
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31240,-0.00472421429333886,0.0229577048164619,-0.0497213157336041,0.0402728871469264,0.836969195944833
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31240,0.0204965101245683,0.015488564403195,-0.00986107610569386,0.0508540963548305,0.185766049197695
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31240,0.0104432267656397,0.0167783221021239,-0.0224422845545233,0.0433287380858026,0.533682473954089
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31240,0.026801722876319,0.0259327640459208,-0.0240264946536859,0.0776299404063238,0.301400026213696
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31240,-7.14615160760773e-05,0.0294699760315035,-0.057832614537823,0.0576896915056708,0.998065283359894
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31240,0.0188089987148883,0.0173669722952695,-0.0152302669838399,0.0528482644136166,0.278829296706463
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31240,-0.0208278229567407,0.0288079257394457,-0.0772913574060542,0.0356357114925728,0.469709350639783
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31240,0.0257980566249691,0.0216397364761535,-0.0166158268682917,0.0682119401182298,0.233236332086341
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31243,0.0582455169008511,0.0301594563646015,-0.000867017573767892,0.11735805137547,0.0534901028162104
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31243,0.0201906035939447,0.0150253655905176,-0.00925911296346975,0.0496403201513592,0.179064755392611
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31243,-0.00200603006276811,0.0203181886536459,-0.041829679823914,0.0378176196983778,0.921354731219505
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31243,0.0338822579855192,0.0342219684432608,-0.0331928001632719,0.10095731613431,0.322170727909717
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20600.Liking for adding salt to foods,33120,-0.0674265020219961,0.0699655516479286,-0.204558983251936,0.069705979207944,0.335216527529874
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20601.Liking for aniseed,33120,-0.0722456363215047,0.0695076416459117,-0.208480613947492,0.0639893413044823,0.298649964233946
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20602.Liking for apple juice,33120,0.163376036102628,0.0694741677685991,0.0272066672761737,0.299545404929082,0.0187132977575358
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20603.Liking for apples,33120,0.0843759748579474,0.0702608448104303,-0.0533352809704959,0.222087230686391,0.2298222520351
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20604.Liking for asparagus,33120,-0.0379063447553866,0.0701897074321715,-0.175478171322443,0.0996654818116695,0.589171687157582
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20605.Liking for aubergine,33120,0.116975486997037,0.0698363462904888,-0.0199037517323213,0.253854725726395,0.0939691342836887
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20606.Liking for avocados,33120,0.111929897203746,0.0699358799610658,-0.0251444275199426,0.249004221927435,0.109529709624442
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20607.Liking for bacon,33120,-0.0573784897866633,0.0709399439960922,-0.196420780019004,0.0816638004456774,0.41863264405117
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20608.Liking for baked or steamed fish,33120,0.0565644823903678,0.0716151624529643,-0.0838012360174423,0.196930200798178,0.429641765579621
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20609.Liking for bananas,33120,0.0161101616191928,0.0722893694222355,-0.125577002448389,0.157797325686775,0.823652051019582
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33120,-0.0946342070180315,0.0706318978188313,-0.233072726742941,0.0438043127068778,0.180335963274112
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20611.Liking for beef steak,33120,-0.138183031071714,0.0707811536086813,-0.276914092144729,0.000548030001301519,0.0509377748320413
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20612.Liking for beetroot,33120,-0.0399445124495024,0.0709412542990538,-0.178989370875648,0.099100345976643,0.573404508169695
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20613.Liking for bell pepper,33120,-0.00950584924577981,0.0701033145353746,-0.146908345735114,0.127896647243554,0.892142262394648
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20614.Liking for bicycling,33120,0.151265845679153,0.0689799889200109,0.0160650673959312,0.286466623962374,0.028339783490822
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20615.Liking for biscuits,33120,-0.00510308026603687,0.0694248619242925,-0.14117580963765,0.130969649105577,0.941405788216675
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20616.Liking for bitter foods,33120,-0.0284758747175494,0.069045462364131,-0.163804980951246,0.106853231516147,0.680039622835619
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20617.Liking for bitter or ale,33120,-0.0680821708349475,0.0701496470559202,-0.205575479064551,0.0694111373946561,0.331808932218137
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20618.Liking for black olives,33120,0.0930675087011269,0.0696226342406795,-0.0433928544106049,0.229527871812859,0.1813396955918
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20619.Liking for black pepper,33120,0.00471267443462063,0.0701447152038947,-0.132770967365013,0.142196316234254,0.946435858508863
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20620.Liking for blue cheese,33120,0.0321801509549354,0.0693191814361655,-0.103685444659949,0.16804574656982,0.642492784181106
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20621.Liking for bolognese sauce,33120,-0.0112134690994286,0.0694130459220906,-0.147263039106726,0.124836100907869,0.871666127224575
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20622.Liking for broad beans,33120,0.058914455358069,0.0689679707081566,-0.0762627672299178,0.194091677946056,0.393000119171998
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20623.Liking for broccoli,33120,0.0701102835008128,0.0708310342001937,-0.0687185435315668,0.208939110533192,0.322285861112908
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20624.Liking for brown rice,33120,0.1140018079627,0.0693402966689426,-0.0219051735084275,0.249908789433827,0.100191236256173
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20625.Liking for brussel sprouts,33120,-0.0160435903980624,0.0696770174423797,-0.152610544585127,0.120523363789002,0.817897504449637
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20626.Liking for burgers (meat),33120,-0.0696167541424115,0.0693760356614247,-0.205593784038804,0.0663602757539808,0.315660504374847
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20627.Liking for burn of spicy foods,33120,-0.0306464056792673,0.0681654595747107,-0.1642507064457,0.102957895087166,0.653017725932356
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20628.Liking for butter on bread,33120,0.120846274700781,0.0705893863972854,-0.0175089226378989,0.25920147203946,0.0869373763831634
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20629.Liking for butternut squash,33120,0.111680097838648,0.0697880030929021,-0.0251043882234402,0.248464583900736,0.109571415566537
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20630.Liking for cabbage,33120,0.0681059546138363,0.0705205226618969,-0.0701142698034816,0.206326179031154,0.334189145787396
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20631.Liking for cake,33120,-0.0704060909825582,0.0683926599735159,-0.204455704530649,0.063643522565533,0.303300210310741
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20632.Liking for cake icing,33120,-0.0319791428857648,0.0697709069951348,-0.168730120596229,0.104771834824699,0.646715401411168
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20633.Liking for capers,33120,-0.046025892937895,0.0689148339167512,-0.181098967414727,0.0890471815389374,0.504235621987213
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20634.Liking for cauliflower,33120,0.0289148674384844,0.0701670586985905,-0.108612567610753,0.166442302487722,0.680285886737094
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20635.Liking for cereal or granola bar,33120,-0.0455825969428185,0.0688839951659747,-0.180595227468129,0.0894300335824919,0.508160841821608
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20636.Liking for cheesecake,33120,0.0487049172203899,0.0688345274417663,-0.0862107565654721,0.183620591006252,0.479233124979548
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20637.Liking for cherries,33120,0.0982841609508648,0.0720544527332706,-0.0429425664063457,0.239510888308075,0.172592506313451
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20638.Liking for chicken,33120,-0.11011186977849,0.0737009946750446,-0.254565819341578,0.034342079784597,0.135200562511861
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20639.Liking for chilli pepper,33120,0.000841178468746464,0.0690279480968155,-0.134453599801012,0.136135956738505,0.990277437154252
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20640.Liking for chips or french fries,33120,-0.0347202055621212,0.0703880970160753,-0.172680875713629,0.103240464589386,0.621834847069887
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20641.Liking for cigarette smoking,33120,-0.00413577268717941,0.108784682552179,-0.217353750489451,0.209082205115092,0.96967417553594
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20642.Liking for cod,33120,-0.0811106530454392,0.0723877558014284,-0.222990654416239,0.0607693483253605,0.262528824121757
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20643.Liking for coffee with sugar,33120,0.0987960049466726,0.0745745809958665,-0.0473701738052258,0.244962183698571,0.185271996984595
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20644.Liking for coffee without sugar,33120,0.0268087282020996,0.0697287563854022,-0.109859634313289,0.163477090717488,0.700637760976635
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20645.Liking for coriander,33120,0.0472636319719629,0.0687687186354935,-0.0875230565536044,0.18205032049753,0.49192108219074
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20646.Liking for corn flakes,33120,0.0230580878706833,0.0694287971077439,-0.113022354460495,0.159138530201861,0.739812744042909
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20647.Liking for cream,33120,0.0223510671117896,0.0688179971625427,-0.112532207326794,0.157234341550373,0.745350988917361
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20648.Liking for croissant,33120,0.06581033008506,0.0693267648470153,-0.07007012901509,0.20169078918521,0.342504349570629
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20649.Liking for cucumber,33120,0.0888109692594633,0.0693696375389282,-0.047153520316836,0.224775458835762,0.200486839005294
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20650.Liking for curry,33120,-0.0470292831219348,0.0703020411560336,-0.184821283787761,0.0907627175438911,0.503537417921071
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20651.Liking for dairy products,33120,0.112282151352973,0.0702001536420161,-0.0253101497853787,0.249874452491324,0.109753168036583
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20652.Liking for dark chocolate,33120,0.0307888814109456,0.0689296531789414,-0.10431323881978,0.165891001641671,0.655123034214817
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20653.Liking for diet fizzy drinks,33120,-0.0412849927681376,0.0713660895126334,-0.181162528212899,0.0985925426766238,0.562943422850471
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20654.Liking for dried fruit,33120,0.0465774693028646,0.0697313384001838,-0.0900959539614956,0.183250892567225,0.504178311377709
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20655.Liking for eggs,33120,0.0426028421025718,0.0707148672716395,-0.0959982977498416,0.181203981954985,0.546883094586762
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20656.Liking for exercising alone,33120,0.0656323270556434,0.0692843103083552,-0.0701649211487329,0.20142957526002,0.343515821497019
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20657.Liking for exercising with others,33120,0.168683247438161,0.0689527990615009,0.0335357612776192,0.303830733598703,0.0144492424090619
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20658.Liking for extra virgin olive oil,33120,0.101025632858476,0.0709137117540801,-0.0379652421795213,0.240016507896473,0.154298602251422
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20659.Liking for fatty foods,33120,-0.0292624454624776,0.0685918324355287,-0.163702437036114,0.105177546111159,0.669668201403893
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20660.Liking for fresh tomatoes,33120,0.115662287329331,0.0742985764110389,-0.0299629224363057,0.261287497094967,0.119570522193094
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20661.Liking for fried chicken,33120,-0.115407767463927,0.0698222302962742,-0.252259338844624,0.0214438039167706,0.0983892229121541
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20662.Liking for fried or battered fish,33120,-0.0572980030016924,0.0708282686115013,-0.196121409480235,0.08152540347685,0.418552731533659
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20663.Liking for fruit,33120,0.114572479395301,0.0770949703132991,-0.0365336624187658,0.265678621209367,0.137281109950767
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20664.Liking for garlic,33120,0.0660444596003759,0.0703359285509047,-0.0718139603593973,0.203902879560149,0.347762393303164
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20665.Liking for gherkins,33120,-0.0907325591204275,0.0692732629400916,-0.226508154483007,0.045043036242152,0.190303651192242
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20666.Liking for globe artichoke,33120,0.121431999769214,0.0694299960703383,-0.0146507925286492,0.257514792067077,0.0803268295357789
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20667.Liking for goat's cheese,33120,0.0311762062773392,0.0692434195114848,-0.104540895965171,0.166893308519849,0.652547436489035
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20668.Liking for going to a cafe,33120,0.0313980343643498,0.0690628275540536,-0.103965107641595,0.166761176370295,0.649386104408439
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20669.Liking for going to the gym,33120,0.141689152055785,0.0673328236410382,0.00971681771935001,0.27366148639222,0.0353783022081818
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20670.Liking for going to the pub,33120,0.0343845484990463,0.0684248234173468,-0.0997281053989533,0.168497202397046,0.615316768156352
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20671.Liking for grapefruit,33120,-0.00587187587521332,0.06810608441881,-0.139359801336081,0.127616049585654,0.931296091036385
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20672.Liking for green olives,33120,0.138814811209498,0.0700983183932944,0.00142210715864111,0.276207515260355,0.0477008319615157
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20673.Liking for haddock,33120,-0.0831919048696641,0.0717295593519215,-0.22378184119943,0.0573980314601021,0.2461603923252
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20674.Liking for ham,33120,-0.135784698504421,0.0704560918545851,-0.273878638539408,0.00230924153056608,0.0539822576365036
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20675.Liking for hard cheese,33120,0.152985916568058,0.0709786769487989,0.0138677097484122,0.292104123387704,0.0311579395118682
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20676.Liking for herring,33120,0.0180648457760676,0.0698987175459961,-0.118936640614085,0.15506633216622,0.796070656555369
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20677.Liking for honey,33120,0.110809052394826,0.0686852817093225,-0.0238140997554457,0.245432204545099,0.106716339813759
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20678.Liking for horseradish or wasabi,33120,0.0344566727379046,0.0694102413414493,-0.101587400291336,0.170500745767145,0.61960949812009
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20679.Liking for ice cream,33120,0.0312458197815312,0.0691696103193981,-0.104326616444489,0.166818256007552,0.651475846325715
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20680.Liking for jam,33120,0.0125439071541463,0.0689185335137576,-0.122536418532819,0.147624232841111,0.855578355076823
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20681.Liking for kiwi fruit,33120,0.061728350381973,0.0691602429667643,-0.073825725832885,0.197282426596831,0.372126258461809
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20682.Liking for lager,33120,0.049113374671536,0.0691230180494051,-0.086367740705298,0.18459449004837,0.477398856073529
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20683.Liking for lamb,33120,-0.060681743672109,0.0704644043904296,-0.198791976277351,0.077428488933133,0.389167423145747
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20684.Liking for lemons,33120,0.0852314210726165,0.0702345817417156,-0.052428359141146,0.222891201286379,0.224960142607844
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20685.Liking for lentils or beans,33120,0.076648563219233,0.0694812477975835,-0.0595346824640307,0.212831808902497,0.269988696862914
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20686.Liking for liver,33120,-0.101200117884197,0.0704497220553639,-0.239281573112711,0.0368813373443159,0.150897596237838
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20687.Liking for mackerel,33120,0.0313225829125953,0.070089761809424,-0.106053350233876,0.168698516059066,0.654963202478722
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20688.Liking for marzipan,33120,0.0603902408378903,0.0695762299343545,-0.0759791698334445,0.196759651509225,0.385432007643914
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20689.Liking for mayonnaise,33120,0.0691825021236549,0.0697272017910258,-0.0674828133867557,0.205847817634066,0.321131710914291
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20690.Liking for melon,33120,0.139280082994215,0.0713388653163053,-0.000544093025743431,0.279104259014173,0.0509240425765297
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20691.Liking for milk chocolate,33120,-0.0305087429272061,0.0704674066559845,-0.168624859972936,0.107607374118524,0.665062433029989
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20692.Liking for mushrooms,33120,0.0165326371068646,0.0714991068552969,-0.123605612329517,0.156670886543247,0.81714233994326
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20694.Liking for orange juice,33120,0.0601635106695862,0.0696529414097831,-0.0763562544935887,0.196683275832761,0.387741461115819
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20695.Liking for oranges,33120,0.022750574437948,0.0696827707918408,-0.11382765631406,0.159328805189956,0.744062705024453
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20696.Liking for pasta,33120,0.0514168653420913,0.0698077317873761,-0.0854062889611657,0.188240019645348,0.461414897700254
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20697.Liking for pears,33120,0.154727974089679,0.0698064355072582,0.0179073604954528,0.291548587683905,0.0266795398804062
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20698.Liking for pizza,33120,0.128617682277015,0.0690315309783188,-0.00668411844049027,0.26391948299452,0.062469600963426
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20699.Liking for plain yogurt,33120,0.0367290859331176,0.0681801595989646,-0.0969040268808529,0.170362198747088,0.590102443390498
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20700.Liking for plums,33120,0.152500347850618,0.0700783697012895,0.01514674323609,0.289853952465145,0.0295700054054109
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20701.Liking for pollock,33120,-0.100140417086186,0.0686542939328769,-0.234702833194625,0.0344219990222528,0.14470411309132
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20702.Liking for pork chop,33120,-0.158800657755658,0.0699940986717446,-0.295989091152278,-0.021612224359039,0.0233051240812846
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20703.Liking for porridge,33120,0.0134069726952328,0.0703178188561245,-0.124415952262771,0.151229897653237,0.848794186709718
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20704.Liking for potato crisps,33120,0.0148518234511699,0.0712089872050746,-0.124717791470776,0.154421438373116,0.834791100351308
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20705.Liking for potatoes,33120,0.0349108206049158,0.0705924747579414,-0.103450429920649,0.173272071130481,0.620936425089048
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20706.Liking for prawns,33120,-0.00699079068905204,0.0703267338565581,-0.144831189047906,0.130849607669802,0.920819299129137
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20707.Liking for raw carrots,33120,0.116866800570306,0.0697612416167138,-0.0198652329984527,0.253598834139065,0.0939210104621135
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20708.Liking for red meat,33120,-0.191182964771076,0.0704118337549655,-0.329190158930808,-0.0531757706113436,0.00663565392947323
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20709.Liking for red wine,33120,0.0110838900713994,0.0689702961694107,-0.124097890420646,0.146265670563444,0.872329047471833
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33120,-0.110126921788237,0.0714974254868057,-0.250261875742376,0.0300080321659023,0.123523363669782
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20711.Liking for roast chicken,33120,0.00756691774529508,0.0744102388827364,-0.138277150464868,0.153410985955459,0.919003444403952
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20712.Liking for salad dressing,33120,0.198816511844755,0.0701035044720711,0.0614136430794961,0.336219380610015,0.00457755564911016
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20713.Liking for salad leaves,33120,0.157741267722193,0.0713058512931321,0.017981799187654,0.297500736256732,0.0269786755859228
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20714.Liking for salami,33120,-0.0989460468460318,0.0706000365792565,-0.237322118541374,0.0394300248493108,0.161097750486529
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20715.Liking for salmon,33120,0.0625815362210672,0.0740206762196369,-0.0824989891694212,0.207662061611556,0.397875807529327
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20716.Liking for salty foods,33120,-0.0194840071974842,0.0701757460579339,-0.157028469471035,0.118060455076066,0.781290408634433
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20717.Liking for salty pretzels,33120,-0.0989981586454908,0.0689857463312414,-0.234210221454724,0.0362139041637423,0.151305981251618
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20718.Liking for sardines,33120,-0.000274013642522876,0.0696840686375175,-0.136854788172057,0.136306760887011,0.996862628899454
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20719.Liking for sausages (meat),33120,-0.0776445286107763,0.0704370757935238,-0.215701197166083,0.0604121399445303,0.270349210289025
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20720.Liking for savoury biscuits,33120,0.061663457608234,0.069938187200783,-0.0754153893053007,0.198742304521769,0.377970027484391
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33120,-0.0990244378137106,0.0690995917318993,-0.234459637608233,0.0364107619808121,0.151872098120625
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20722.Liking for skimmed milk,33120,0.0323811213296808,0.0696575965930085,-0.104147767992616,0.168910010651977,0.642041722508875
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20723.Liking for smoked fish,33120,-0.0776455557755623,0.069699808009522,-0.214257179474225,0.0589660679231007,0.265308315284455
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20724.Liking for soft cheese,33120,0.00855475328948991,0.069727058252089,-0.128110280884605,0.145219787463584,0.902355923577716
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20725.Liking for soy sauce,33120,-0.0761480069700186,0.0690977914280049,-0.211579678168908,0.059283664228871,0.270476242981489
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20726.Liking for soya milk,33120,0.0888246432043181,0.0687988550518799,-0.0460211126973664,0.223670399106003,0.196709119413918
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20727.Liking for spicy foods,33120,-0.0214627282550596,0.0691623327198601,-0.157020900385985,0.114095443875866,0.756321611025584
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20728.Liking for spinach,33120,-0.0260985604637633,0.0703409505323466,-0.163966823507163,0.111769702579636,0.71062413228479
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20729.Liking for spirits,33120,-0.0719460778398994,0.0695012931247482,-0.208168612364406,0.0642764566846071,0.300613734857338
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20730.Liking for strawberries,33120,0.106107709109519,0.0755339894673563,-0.0419389102464996,0.254154328465537,0.160123940464972
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33120,-0.0710305192614591,0.0714563934496776,-0.211085050422827,0.069024011899909,0.320229352845601
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20732.Liking for sweet foods,33120,-0.0629239612488631,0.0692771371529552,-0.198707150068655,0.0728592275709291,0.3637469286783
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20733.Liking for taking the stairs,33120,0.0474610298458139,0.0709535991605451,-0.0916080245088544,0.186530084200482,0.503574456517275
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20734.Liking for tea with sugar,33120,0.0105230141272426,0.0830223980949172,-0.152200886138795,0.17324691439328,0.899141738704444
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20735.Liking for tea without sugar,33120,0.0231341702897057,0.0714500516297327,-0.11690793090457,0.163176271483982,0.746111149183868
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20736.Liking for tomato ketchup,33120,-0.0855430621249926,0.0686004791012441,-0.220000001163431,0.0489138769134459,0.212438342329526
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20737.Liking for tinned tuna,33120,0.0850193005198016,0.0710268717760423,-0.0541933681612412,0.224231969200844,0.231336486518091
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20738.Liking for turnip (white),33120,0.0509846260129658,0.0692736034092844,-0.0847916366692317,0.186760888695163,0.461755912822832
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20739.Liking for vegetables,33120,0.160700362178392,0.0777339932311546,0.00834173544532882,0.313058988911455,0.0387325773257548
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20740.Liking for vinegar,33120,-0.040616731876874,0.070770630898186,-0.179327168437319,0.0980937046835706,0.56603539977437
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20741.Liking for watching television,33120,-0.0539401617771441,0.0703775162725475,-0.191880093671337,0.083999770117049,0.443433942740346
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20742.Liking for whisky,33120,-0.0495035223568293,0.0709090549808732,-0.188485270119341,0.0894782254056821,0.485115351844237
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20743.Liking for white bread,33120,-0.0393215403954459,0.0685145109194243,-0.173609981797518,0.0949669010066257,0.566038930372551
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20744.Liking for white rice,33120,-0.0205047860849503,0.0692604759783548,-0.156255319002526,0.115245746832625,0.767196092959783
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20745.Liking for white wine,33120,0.0475135666813031,0.0699396898148151,-0.0895682253557344,0.184595358718341,0.496932771428182
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33120,0.0500748729813274,0.0692205828258944,-0.0855974693574257,0.185747215320081,0.469446220596036
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20747.Liking for whole milk,33120,-0.0843094274130042,0.0678076783335515,-0.217212476946765,0.0485936221207567,0.213766318071054
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20748.Liking for wholemeal bread,33120,0.109109009799622,0.0721833731353308,-0.0323704015456269,0.25058842114487,0.130681717804034
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20749.Liking for working up a sweat,33120,0.12988724617923,0.0690530379463609,-0.00545670819563768,0.265231200554097,0.0600062911817754
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21001.Body mass index (BMI),47475,-0.00258359100639787,0.00724906737594479,-0.0167917630632497,0.0116245810504539,0.721541797012357
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21002.Weight,47494,0.00613452380271575,0.00423343045919201,-0.0021629998973006,0.0144320475027321,0.147332178144952
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21021.Pulse wave Arterial Stiffness index,31653,-0.000968064772780516,0.00328128742338911,-0.00739938812262318,0.00546325857706215,0.767981954165004
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32659,-0.0549460144926173,0.0727938412351305,-0.197621943313473,0.0877299143282385,0.450379123876885
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32659,-0.103029327502036,0.0762433814564827,-0.252466355156742,0.0464077001526699,0.176627192196689
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32659,-0.0116013927937934,0.0747818598598759,-0.15817383811915,0.134971052531563,0.876717301122973
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21040.Satisfaction with bowel habits,32632,-0.0270258530028599,0.0683941216943059,-0.1610783315237,0.10702662551798,0.69274271678446
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32631,-0.0494110626863,0.072658242670007,-0.191821218319514,0.0929990929469137,0.496492296003202
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21042.Greatest number of times bowels opened per day,32625,0.081638537908606,0.0762006172263828,-0.0677146718551042,0.230991747672316,0.284035650232746
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21043.Least number of times bowels opened per week,32572,-0.0272507993395506,0.0734344696584064,-0.171182359870027,0.116680761190926,0.710579503022089
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21044.Average number of times bowels opened per day,32609,-0.00736141925978367,0.0825915293354282,-0.169240816757223,0.154517978237656,0.928980288880512
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32663,0.0107845061049488,0.0744197545579164,-0.135078212828567,0.156647225038465,0.884781647270118
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32657,-0.0337141903297894,0.0759389911532091,-0.182554612990079,0.1151262323305,0.657079418049271
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,29008,-0.002624249258032,0.110242259002676,-0.218699076903277,0.213450578387213,0.981009564502009
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32661,0.0320282039896767,0.0788126374884408,-0.122444565487667,0.186500973467021,0.684470271068976
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32658,0.0842716525474184,0.114443725018269,-0.140038048488389,0.308581353583226,0.461531960486541
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32661,-0.047083188229289,0.0889626184307294,-0.221449920353519,0.127283543894941,0.59664754947257
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32660,0.160957066869697,0.231325350115125,-0.292440619355949,0.614354753095343,0.486570060976484
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32662,0.0126071676043482,0.0844557770864014,-0.152926155484999,0.178140490693695,0.881339767522757
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32661,-0.00382787758710264,0.0878255313221686,-0.175965918978553,0.168310163804348,0.965236181096109
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32450,-0.0207060178670072,0.0790535668635798,-0.175651008919624,0.134238973185609,0.793386401414708
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32661,-0.0599144625557677,0.0777767042795532,-0.212356802943692,0.0925278778321565,0.441119248281708
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32662,0.316947175121802,0.112050030842942,0.0973291146696358,0.536565235573968,0.00468545799742716
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32661,0.06104504442723,0.0763620803585338,-0.0886246330754962,0.210714721929956,0.424070997869626
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32660,-0.0633908108058977,0.0757809233815359,-0.211921420633708,0.0851397990219126,0.402895885527816
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X21100.Water hardness (USGS classification),47277,0.00915311379898039,0.0472146427241234,-0.0833875859403015,0.101693813538262,0.846285807323126
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2139.Age first had sexual intercourse,44959,0.00372630253496869,0.00195541320166099,-0.000106307340286854,0.00755891241022424,0.0567112418544839
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2149.Lifetime number of sexual partners,43272,0.0232437548718542,0.0526386737786456,-0.0799280457342913,0.126415555478,0.658803999912112
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22032.IPAQ activity group,43245,0.0132294614349398,0.0509646069785562,-0.0866611682430302,0.11312009111291,0.795189481293309
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22033.Summed days activity,43735,0.000739484130313789,0.001863082574362,-0.00291215771543573,0.0043911259760633,0.6914349147666
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22034.Summed minutes activity,43245,-0.000682064510619952,0.00190406429420893,-0.00441403052726945,0.00304990150602955,0.720186276267851
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22037.MET minutes per week for walking,42592,-0.00258694547430162,0.00188421997456383,-0.00628001662444673,0.00110612567584349,0.169783392149789
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22038.MET minutes per week for moderate activity,43245,0.000428921313205627,0.00195249766953035,-0.00339797411907386,0.00425581674548511,0.826124041183409
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22039.MET minutes per week for vigorous activity,43245,0.0514204005156439,0.0507916990101513,-0.0481313295442526,0.15097213057554,0.311369972113756
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22040.Summed MET minutes per week for all activity,42592,0.000244602687738343,0.00193527671813016,-0.00354853967979678,0.00403774505527346,0.899423321117971
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X2217.Age started wearing glasses or contact lenses,42777,-0.00244156227246782,0.00225016408039411,-0.00685188387004027,0.00196875932510463,0.277909059975341
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X22501.Year ended full time education,29887,-0.000217539527161688,0.00993774528406547,-0.01969552028393,0.0192604412296066,0.982536243106687
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X22506.Tobacco smoking,29846,0.10836388442171,0.180866379204541,-0.24613421881919,0.46286198766261,0.549103678030221
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,45871,0.0609855315507517,0.0994308310298545,-0.133898897267763,0.255869960369267,0.539653728293747
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23098.Weight,47167,0.00651251201855534,0.00426240926874127,-0.00184181014817755,0.0148668341852882,0.126552284419965
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23099.Body fat percentage,47146,-0.00640694940576628,0.00412254204787807,-0.0144871318196073,0.00167323300807473,0.120167976310858
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23100.Whole body fat mass,47116,-0.00278501011828872,0.00392609095612525,-0.0104801483922942,0.00491012815571677,0.478108493395389
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23101.Whole body fat-free mass,47163,0.00678580446218413,0.00363652415660027,-0.000341782884752402,0.0139133918091207,0.0620519801210934
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23102.Whole body water mass,47167,0.00712273826475349,0.00363595272029012,-3.7290670151539e-06,0.0142492055965221,0.0501276912254511
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23104.Body mass index (BMI),47167,-0.00433475910183894,0.00730596744399712,-0.0186544552920733,0.0099849370883954,0.552974376728913
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23105.Basal metabolic rate,47165,0.00735588522669206,0.00389718676047541,-0.00028260082383974,0.0149943712772239,0.0591074096182078
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23106.Impedance of whole body,47164,-0.00431205569043684,0.0029836279233808,-0.0101599664202632,0.00153585503938953,0.148404187736084
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23107.Impedance of leg (right),47164,-0.00240625410061662,0.00246555715696141,-0.00723874612826098,0.00242623792702774,0.329100660852949
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23108.Impedance of leg (left),47163,-0.00291339020432265,0.00243943446610765,-0.00769468175789364,0.00186790134924835,0.232377022274153
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23109.Impedance of arm (right),47158,-0.00379283874645768,0.00300154083679619,-0.00967585878657821,0.00209018129366285,0.206375301101555
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23110.Impedance of arm (left),47162,-0.00291103014431128,0.00299282410558198,-0.00877696539125196,0.00295490510262941,0.330727449483568
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23111.Leg fat percentage (right),47163,-0.0043601661600169,0.00509233722665927,-0.0143411471242691,0.00562081480423527,0.391884343497166
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23112.Leg fat mass (right),47162,-0.00360600372721588,0.00527650902518299,-0.0139479614165745,0.00673595396214277,0.494356430277142
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23113.Leg fat-free mass (right),47162,0.0058647215769163,0.00391005175155909,-0.00179897985613952,0.0135284230099721,0.133651539896601
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23114.Leg predicted mass (right),47161,0.00585893714183323,0.00392795855790007,-0.0018398616316509,0.0135577359153174,0.135817966022856
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23115.Leg fat percentage (left),47160,-0.00646212948220998,0.00525619768838453,-0.0167642769514437,0.00384001798702369,0.218922874693547
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23116.Leg fat mass (left),47160,-0.00422917885506645,0.0054781322895183,-0.0149663181425223,0.00650796043238942,0.440115691801601
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23117.Leg fat-free mass (left),47158,0.00645709275404866,0.00405364969686701,-0.00148806065181069,0.014402246159908,0.11119430190085
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23118.Leg predicted mass (left),47157,0.00617281735715092,0.00407044115592785,-0.00180524730846766,0.0141508820227695,0.129406951408212
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23119.Arm fat percentage (right),47157,-0.00612563233655812,0.00456216940920107,-0.0150674843785922,0.00281621970547598,0.179381686157325
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23120.Arm fat mass (right),47156,-0.000397647685338149,0.00445606582502557,-0.00913153670238827,0.00833624133171197,0.928894017828306
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23121.Arm fat-free mass (right),47155,0.006762635364993,0.00364360718737334,-0.000378834722258751,0.0139041054522448,0.0634622485418514
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23122.Arm predicted mass (right),47154,0.00779880015364894,0.00364383894648269,0.00065687581854287,0.014940724488755,0.0323432855958748
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23123.Arm fat percentage (left),47151,-0.00447892695150457,0.0046546991901828,-0.0136021373642629,0.00464428346125373,0.335940215017221
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23124.Arm fat mass (left),47151,-0.00107094299398523,0.00443618514651255,-0.00976586588114983,0.00762397989317936,0.809238870175635
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23125.Arm fat-free mass (left),47147,0.00775495836171315,0.00369713160467458,0.000508580416550971,0.0150013363068753,0.0359547117334527
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23126.Arm predicted mass (left),47146,0.00698597077177111,0.00371810884157162,-0.000301522557709264,0.0142734641012515,0.0602700390133556
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23127.Trunk fat percentage,47144,-0.0035327497379603,0.00295518316221249,-0.00932490873589677,0.00225940925997617,0.231926603139714
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23128.Trunk fat mass,47140,-0.00176256493697432,0.00322549740773271,-0.00808453985613044,0.0045594099821818,0.584763615756894
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23129.Trunk fat-free mass,47135,0.0065203098139845,0.00331143154374962,2.9903988235238e-05,0.0130107156397338,0.0489614294943287
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23130.Trunk predicted mass,47133,0.00654599466872743,0.0033056411820994,6.69379518126057e-05,0.0130250513856423,0.0476872453846994
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23400.Total Cholesterol,36962,0.00521510612911996,0.00251064537373949,0.00029424119659056,0.0101359710616494,0.0378027757948475
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,36962,0.00294088704545155,0.00243603637844037,-0.00183374425629158,0.00771551834719468,0.227360498374386
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",36962,0.00188581374742955,0.00244580272891258,-0.00290795960123911,0.00667958709609821,0.440696639358533
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23403.VLDL Cholesterol,36962,-0.0011124962622331,0.00240588770094534,-0.00582803615608597,0.00360304363161977,0.643798068570583
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23404.Clinical LDL Cholesterol,36962,0.00418216614405572,0.00243172488412867,-0.000584014628836466,0.0089483469169479,0.0854860110357826
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23405.LDL Cholesterol,36962,0.00377827059059705,0.00241355567294464,-0.00095229852837444,0.00850883970956854,0.117504508819949
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23406.HDL Cholesterol,36962,0.00882137994399498,0.00274985400879259,0.00343166608676151,0.0142110938012285,0.00134008625305228
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23407.Total Triglycerides,36962,-0.00435820525612302,0.00246322800010162,-0.00918613213632219,0.00046972162407615,0.0768660012715525
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23408.Triglycerides in VLDL,36962,-0.00410031125214609,0.00250199292900104,-0.00900421739298812,0.000803594888695942,0.101275162436788
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23409.Triglycerides in LDL,36962,-0.00332700461105521,0.00235667223844819,-0.00794608219841366,0.00129207297630325,0.158050760373803
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23410.Triglycerides in HDL,36962,-0.00644406044297895,0.00232502460403459,-0.0110011086668868,-0.00188701221907115,0.00558585902529205
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,36962,0.00395656111679095,0.00248491690352725,-0.000913876014122463,0.00882699824770437,0.111356989091034
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23412.Phospholipids in VLDL,36962,-0.00266956604115587,0.00242984366013751,-0.00743205961502539,0.00209292753271365,0.271937660881765
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23413.Phospholipids in LDL,36962,0.00356255546392392,0.0024146022666355,-0.00117006497868166,0.0082951759065295,0.140123358969076
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23414.Phospholipids in HDL,36962,0.00517090557668127,0.0025808738116701,0.000112392905807881,0.0102294182475547,0.0451390123562656
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23415.Total Esterified Cholesterol,36962,0.00568397451495363,0.00251970426367997,0.000745354158140891,0.0106225948717664,0.0240989435444838
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,36962,-0.000521797733779122,0.00240632681292385,-0.00523819828710987,0.00419460281955163,0.828333231316687
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23417.Cholesteryl Esters in LDL,36962,0.00326128353973846,0.00240478538926442,-0.00145209582321981,0.00797466290269673,0.175070341753734
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23418.Cholesteryl Esters in HDL,36962,0.00916686427392761,0.00274362446563371,0.00378936032128554,0.0145443682265697,0.000836649908920765
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23419.Total Free Cholesterol,36962,0.00397066581445016,0.00248556316094483,-0.000901037981001703,0.00884236960990203,0.110180324777127
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23420.Free Cholesterol in VLDL,36962,-0.00188392064388884,0.00241802378971499,-0.00662324727173022,0.00285540598395255,0.43592554985558
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23421.Free Cholesterol in LDL,36962,0.00505244953210058,0.00244053153455251,0.000269007724377652,0.0098358913398235,0.0384508190894243
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23422.Free Cholesterol in HDL,36962,0.00695210421474139,0.00272739697732039,0.00160640613919342,0.0122978022902893,0.0108148771893313
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,36962,0.002485405890656,0.0024222305076927,-0.00226216590442168,0.00723297768573368,0.304872117011767
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23424.Total Lipids in VLDL,36962,-0.00300373317375242,0.00245093248217487,-0.00780756083881518,0.00180009449131033,0.220391187821076
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23425.Total Lipids in LDL,36962,0.00332727083527481,0.00241126608513186,-0.00139881069158362,0.00805335236213325,0.167645482692071
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23426.Total Lipids in HDL,36962,0.00614433046856103,0.00263881871018564,0.000972245796597171,0.0113164151405249,0.0199038992356061
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,36962,0.00626361892713517,0.00249035992870069,0.00138251346688182,0.0111447243873885,0.0119101767343332
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23428.Concentration of VLDL Particles,36962,-0.00230764410002106,0.00240011736684013,-0.00701187413902771,0.00239658593898559,0.33633296430477
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23429.Concentration of LDL Particles,36962,0.00204958024345002,0.00241481345408894,-0.00268345412656429,0.00678261461346433,0.39603423597721
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23430.Concentration of HDL Particles,36962,0.00621879984304297,0.00248892916935292,0.00134049867111124,0.0110971010149747,0.0124811917610356
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23431.Average Diameter for VLDL Particles,36962,-0.00361868016868345,0.00262160400512188,-0.00875702401872233,0.00151966368135543,0.167508433803964
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23432.Average Diameter for LDL Particles,36962,0.0082733635801366,0.0024053156115951,0.0035589449814102,0.012987782178863,0.000584352873967733
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23433.Average Diameter for HDL Particles,36962,0.00420975369038856,0.00278776996670438,-0.00125427544435203,0.00967378282512914,0.131047308316715
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23434.Phosphoglycerides,36950,0.00336597759854366,0.002456259913749,-0.00144829183240439,0.0081802470294917,0.170595858908166
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,36950,-0.00731474612310024,0.00263557301575139,-0.012480469233973,-0.00214902301222752,0.0055213585482105
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23436.Total Cholines,36950,0.0043669499395121,0.00249853433998879,-0.000530177366865925,0.00926407724589013,0.0805213052411276
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23437.Phosphatidylcholines,36950,0.0038490931751608,0.0024913461598396,-0.00103394529812482,0.00873213164844642,0.122373994760592
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23438.Sphingomyelins,36949,0.00712493390425888,0.00257890500781431,0.00207028008894284,0.0121795877195749,0.00573922962153978
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23439.Apolipoprotein B,36962,0.00172903243025645,0.00242365470153833,-0.00302133078475869,0.00647939564527158,0.475611702900792
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23440.Apolipoprotein A1,36962,0.00563266385993024,0.00256450528776265,0.000606233495915456,0.010659094223945,0.0280812164113591
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,36962,-0.00132840123502724,0.00241746975356648,-0.00606664195201753,0.00340983948196305,0.582671274478259
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23442.Total Fatty Acids,36950,-0.00056328716385269,0.00235887177889436,-0.00518667585048563,0.00406010152278025,0.811268161652198
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23443.Degree of Unsaturation,36950,0.00523860342538986,0.00260231448173224,0.000138067041194669,0.010339139809585,0.0441292267695172
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23444.Omega-3 Fatty Acids,36950,0.000548682279482906,0.00239597853854291,-0.0041474356560612,0.00524480021502701,0.818871457508527
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23445.Omega-6 Fatty Acids,36950,0.00211595074489163,0.00239417019266507,-0.0025766228327319,0.00680852432251516,0.376824222585712
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,36950,0.002167556999575,0.00239752615743178,-0.00253159426899128,0.00686670826814128,0.365969277276002
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23447.Monounsaturated Fatty Acids,36950,-0.0029247821401495,0.00239665609097684,-0.00762222807846412,0.00177266379816511,0.222350589319879
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23448.Saturated Fatty Acids,36950,-0.000779031103995993,0.00236912973668478,-0.00542252538789815,0.00386446317990617,0.742292582002728
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23449.Linoleic Acid,36950,0.00148942706919013,0.00241176686699235,-0.00323763599011488,0.00621649012849513,0.536871699015539
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23450.Docosahexaenoic Acid,36950,0.00462512922527949,0.00250274069094138,-0.000280242528965614,0.0095305009795246,0.0646211613830903
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,36950,0.000793779179225797,0.00242173655974309,-0.00395282447787067,0.00554038283632226,0.743088757175766
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,36950,0.00444890234468061,0.00245981747354839,-0.000372339903474227,0.00927014459283544,0.070531271981832
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,36950,0.00559503867118567,0.00255571635975758,0.00058583460606081,0.0106042427363105,0.0285980719364493
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,36950,-0.00737254500687763,0.00261741413436858,-0.01250267671024,-0.00224241330351522,0.0048588136100085
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,36950,-0.0013169357526991,0.00235697672881381,-0.00593661014117416,0.00330273863577597,0.576349146363792
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,36950,0.00373198519161158,0.00251558934690768,-0.00119856992832747,0.00866254031155064,0.137954253094429
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,36950,0.00505847492126387,0.00252730020231998,0.000104966524716707,0.010011983317811,0.0453555756991678
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,36950,0.00684897868386361,0.00261268374517797,0.00172811854331479,0.0119698388244124,0.0087661909896873
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,36948,0.000461496264712402,0.00240088150850499,-0.00424423149195739,0.00516722402138219,0.847573247057646
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23460.Alanine,36958,-0.000131677532219795,0.0023385100559877,-0.00471515724195568,0.00445180217751609,0.955097063565979
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23461.Glutamine,36922,0.00187460373557468,0.00232538463484443,-0.0026831501487204,0.00643235761986977,0.420172302081525
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23462.Glycine,36946,0.00325319662788102,0.00241907951158351,-0.00148819921482266,0.0079945924705847,0.178710666964052
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23463.Histidine,36947,0.0020233899243812,0.00230540547429094,-0.00249520480522905,0.00654198465399144,0.380137834117513
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),36950,0.000780575514039019,0.00246686253650145,-0.00405447505750383,0.00561562608558186,0.751685439727
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23465.Isoleucine,36960,0.000658072277797146,0.00240299639504033,-0.00405180065648189,0.00536794521207619,0.784200468316323
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23466.Leucine,36961,0.001098097075641,0.00247590717502028,-0.00375468098739874,0.00595087513868075,0.657402025747212
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23467.Valine,36950,0.000588448837174764,0.00245916560403738,-0.0042315157467385,0.00540841342108803,0.810886010387369
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23468.Phenylalanine,36958,0.00274858650668753,0.00231920293073715,-0.00179705123755728,0.00729422425093234,0.235982518345049
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23469.Tyrosine,36947,0.000747212375788586,0.00239135678064357,-0.00393984691427281,0.00543427166584998,0.754693064833642
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23470.Glucose,36941,0.00494145779405774,0.0023840479364438,0.000268723838627892,0.00961419174948759,0.0382181187124761
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23471.Lactate,36940,-0.000109351389921328,0.00234549674387785,-0.00470652500792191,0.00448782222807926,0.962815331464602
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23472.Pyruvate,36919,0.00318179897507723,0.00231595917595425,-0.0013574810097931,0.00772107895994756,0.169509360618748
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23473.Citrate,36961,0.00507829467981477,0.00236472447899972,0.000443434700975315,0.00971315465865423,0.0317701433798541
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23474.3-Hydroxybutyrate,36756,0.00201255875601947,0.00231694889041713,-0.0025286610691981,0.00655377858123704,0.385068670392733
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23475.Acetate,36953,0.00786315527581231,0.00231518456957462,0.00332539351944606,0.0124009170321786,0.000684963581253673
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23476.Acetoacetate,36962,0.00119879733544673,0.00229931728757838,-0.00330786454820689,0.00570545921910034,0.602117167173297
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23477.Acetone,36962,0.00820436345739399,0.00231081679433168,0.0036751625405039,0.0127335643742841,0.000385969543711879
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23478.Creatinine,36624,0.0025909137552291,0.00289406295687677,-0.00308144964024936,0.00826327715070756,0.370669624871061
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23479.Albumin,36961,0.00493333768600053,0.00236978575871028,0.000288557598928378,0.00957811777307268,0.0373832799124774
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23480.Glycoprotein Acetyls,36962,-0.0027815126416324,0.00247883544807818,-0.00764003011986563,0.00207700483660082,0.261838534494463
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,36962,-0.00516657164691684,0.00249138553427618,-0.0100496872940982,-0.000283455999735528,0.0381197531082904
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,36962,-0.00470848242243761,0.00250547032044947,-0.00961920425051858,0.000202239405643356,0.0602283305834763
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,36962,-0.00599680842179231,0.00250810040907247,-0.0109126852235744,-0.00108093162001026,0.01681766828066
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,36962,-0.00522676172533338,0.00248620045713692,-0.0100997146213217,-0.000353808829345011,0.0355452454336619
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,36962,-0.00453567137687026,0.00249313946580417,-0.00942222472984643,0.000350881976105916,0.0688944352961697
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,36962,-0.0056513679398242,0.00246925547344633,-0.010491108667779,-0.000811627211869398,0.0221130319669067
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,36962,-0.00369277179938161,0.00250129793328235,-0.00859531574861501,0.00120977214985179,0.13987607213482
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,36962,-0.00470268936315386,0.00252860805360834,-0.00965876114822621,0.00025338242191849,0.0629371124658045
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,36962,-0.00430193820377553,0.00253182557332751,-0.00926431632749744,0.000660439919946386,0.0893156475579369
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,36962,-0.00419081194714242,0.00251865561442655,-0.00912737695141845,0.000745753057133619,0.0961546730733408
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,36962,-0.00357457927436628,0.00248231775338833,-0.0084399220710074,0.00129076352227484,0.149886538269762
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,36962,-0.00283531756968799,0.00246041973715537,-0.00765774025451251,0.00198710511513653,0.249189474550537
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,36962,-0.00414974943355833,0.00249867726496645,-0.00904715687289257,0.000747658005775915,0.0967818719751518
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,36962,-0.00461236227299493,0.00255488932146274,-0.00961994534306191,0.000395220797072046,0.0710494357388485
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23495.Concentration of Large VLDL Particles,36962,-0.00381783192259774,0.00250300104383617,-0.00872371396851663,0.00108805012332115,0.127207983461341
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23496.Total Lipids in Large VLDL,36962,-0.003253163119919,0.00250407823820526,-0.00816115646680131,0.00165483022696332,0.193916704533295
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23497.Phospholipids in Large VLDL,36962,-0.00415601278792182,0.002518994628103,-0.00909324225900371,0.000781216683160065,0.098993570062384
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23498.Cholesterol in Large VLDL,36962,-0.00339878710416848,0.00246365645968456,-0.00822755376515022,0.00142997955681326,0.167742553312874
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,36962,-0.00274929221549156,0.0024242456919268,-0.00750081377166809,0.00200222934068497,0.256781107780894
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,36962,-0.0040216830980463,0.00250753800680307,-0.00893645759138032,0.000893091395287719,0.108774014008245
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23501.Triglycerides in Large VLDL,36962,-0.00271733641610252,0.00251620910373104,-0.00764910625941535,0.00221443342721032,0.2801920425504
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,36962,-0.000269260449602294,0.00240210909099569,-0.00497739426795384,0.00443887336874925,0.910751109100849
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23503.Total Lipids in Medium VLDL,36962,-0.000675687695543634,0.00240956358236123,-0.00539843231697164,0.00404705692588437,0.779160398197977
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23504.Phospholipids in Medium VLDL,36962,-4.07016724717282e-05,0.00240303848598197,-0.00475065710499639,0.00466925376005294,0.986486665188141
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23505.Cholesterol in Medium VLDL,36962,0.00219807370509916,0.00242589195069275,-0.00255667451825863,0.00695282192845695,0.364905476378021
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,36962,0.00334095869114222,0.00245132971657291,-0.00146364755334068,0.00814556493562511,0.172932125419103
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,36962,0.000668238386961233,0.00240180371863627,-0.00403929690156585,0.00537577367548831,0.780845138801448
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23508.Triglycerides in Medium VLDL,36962,-0.00261240032711883,0.00246494126982849,-0.00744368521598268,0.00221888456174502,0.289244875674601
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23509.Concentration of Small VLDL Particles,36962,-0.00337538228763414,0.00240829543340903,-0.00809564133711584,0.00134487676184756,0.161068909755045
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23510.Total Lipids in Small VLDL,36962,-0.00292773884148454,0.00240319541379313,-0.00763800185251907,0.00178252416954999,0.22314364504747
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23511.Phospholipids in Small VLDL,36962,-0.00103650905262094,0.00238964326381148,-0.00572020984969145,0.00364719174444957,0.664476744128406
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23512.Cholesterol in Small VLDL,36962,-0.00112645973957222,0.00239379128911553,-0.00581829066623866,0.00356537118709423,0.637951678604277
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,36962,-0.00203601787231684,0.00239698716298957,-0.0067341127117764,0.00266207696714271,0.395670333448713
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,36962,0.000457132926541936,0.00239661269352711,-0.00424022795277119,0.00515449380585507,0.84873126606547
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23515.Triglycerides in Small VLDL,36962,-0.00513236718560165,0.00242952413394857,-0.00989423448814084,-0.000370499883062455,0.0346625433602553
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,36962,-0.00153906138192453,0.00241051631644076,-0.00626367336214843,0.00318555059829936,0.523173799216665
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,36962,-0.00142490298687298,0.00240158277614451,-0.00613200522811623,0.00328219925437026,0.552978402042959
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,36962,-0.00206923015551874,0.00238559248453344,-0.00674499142520428,0.00260653111416679,0.385746290171246
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,36962,0.00100653276742182,0.00249003488031489,-0.00387393559799536,0.00588700113283899,0.686054336495212
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,36962,0.00184881563988553,0.00252267120953209,-0.00309561993079736,0.00679325121056842,0.463644645615916
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,36962,-0.000835428145540024,0.00241838141312841,-0.0055754557152717,0.00390459942419166,0.729762171880702
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,36962,-0.00543040876837179,0.00236235524745182,-0.0100606250533774,-0.000800192483366219,0.0215361343571078
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23523.Concentration of IDL Particles,36962,0.00246544346120258,0.00247843452320918,-0.00239228820428741,0.00732317512669258,0.319872173699958
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23524.Total Lipids in IDL,36962,0.00428068303627023,0.0025361979489784,-0.000690264943727439,0.0092516310162679,0.0914667551542285
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23525.Phospholipids in IDL,36962,0.00363224544372133,0.00253439336636211,-0.00133516555434841,0.00859965644179106,0.151829863246123
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23526.Cholesterol in IDL,36962,0.00526139924548112,0.00255064815907621,0.000262128853691739,0.0102606696372705,0.039154194259991
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23527.Cholesteryl Esters in IDL,36962,0.00557512334039623,0.0025482726787461,0.000580508890053868,0.0105697377907386,0.0287014246701689
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23528.Free Cholesterol in IDL,36962,0.00421159668933054,0.00254596554234049,-0.000778495773656808,0.0092016891523179,0.0981060112783443
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23529.Triglycerides in IDL,36962,-0.00392415723169494,0.00233312191076013,-0.00849707617678479,0.000648761713394909,0.09260545579484
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23530.Concentration of Large LDL Particles,36962,0.00341598549687379,0.00241968124764195,-0.00132658974850443,0.008158560742252,0.158047272806332
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23531.Total Lipids in Large LDL,36962,0.00411344745413069,0.00243074736052692,-0.000650817372502073,0.00887771228076345,0.0906208997101735
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23532.Phospholipids in Large LDL,36962,0.00404975677955627,0.00243606955406981,-0.000724939546420566,0.00882445310553311,0.0964536610650801
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23533.Cholesterol in Large LDL,36962,0.00466329924645748,0.00243447372872201,-0.000108269261837659,0.00943486775475261,0.0554471200019319
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,36962,0.00437410164292928,0.00242100781796053,-0.000371073680273364,0.00911927696613192,0.070827694987528
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23535.Free Cholesterol in Large LDL,36962,0.00531341516216303,0.00247353019987816,0.000465295970401836,0.0101615343539242,0.0317232895291618
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23536.Triglycerides in Large LDL,36962,-0.00302604862020197,0.00234348066225228,-0.00761927071821644,0.0015671734778125,0.196635461615376
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23537.Concentration of Medium LDL Particles,36962,-0.000340421673482812,0.0024005689622921,-0.00504553683957532,0.0043646934926097,0.887233256152461
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23538.Total Lipids in Medium LDL,36962,0.0019343303353504,0.00239092722996592,-0.00275188703538281,0.00662054770608361,0.418512947199523
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23539.Phospholipids in Medium LDL,36962,0.00260157567877523,0.00238664963745027,-0.00207625761062729,0.00727940896817775,0.27570964576203
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23540.Cholesterol in Medium LDL,36962,0.00210615105077765,0.00239108638745403,-0.00258037826863225,0.00679268037018756,0.378423635758404
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,36962,0.00123661596579505,0.00239454481167857,-0.00345669186509495,0.00592992379668505,0.605562486566555
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,36962,0.00434914583501588,0.00239021683189833,-0.00033567915550485,0.0090339708255366,0.0688486638773232
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23543.Triglycerides in Medium LDL,36962,-0.00342104935111273,0.00237560992413932,-0.0080772448024258,0.00123514610020034,0.149870921129526
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23544.Concentration of Small LDL Particles,36962,0.000407379298579021,0.00241293198332324,-0.00432196738873453,0.00513672598589258,0.86593166535076
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23545.Total Lipids in Small LDL,36962,0.00234474603978077,0.00240938413333262,-0.00237764686155116,0.0070671389411127,0.33048561228326
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23546.Phospholipids in Small LDL,36962,0.00331857510133541,0.00241409947909072,-0.00141305987768239,0.00805021008035322,0.169259216364841
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23547.Cholesterol in Small LDL,36962,0.00254789691803923,0.00240456150175838,-0.00216504362540719,0.00726083746148565,0.289341689310129
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,36962,0.00161022025768848,0.00240679159920693,-0.0031070912767571,0.00632753179213406,0.503486943239946
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23549.Free Cholesterol in Small LDL,36962,0.00492967249487312,0.00239331123254414,0.000238782479086611,0.00962056251065962,0.0394401696550261
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23550.Triglycerides in Small LDL,36962,-0.00408791847754154,0.00240482872899223,-0.0088013827863663,0.000625545831283231,0.0891773744393388
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,36962,0.00448912022543367,0.00281143186479419,-0.00102128622956294,0.00999952668043029,0.110348227391068
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23552.Total Lipids in Very Large HDL,36962,0.00489882152847092,0.00281578718873412,-0.00062012136144796,0.0104177644183898,0.0819229283869099
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23553.Phospholipids in Very Large HDL,36962,0.00424180565083687,0.0027822797432557,-0.0012114626459443,0.00969507394761804,0.127388240424926
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23554.Cholesterol in Very Large HDL,36962,0.00630995247383531,0.00286135836449508,0.000701690079424958,0.0119182148682457,0.0274552839526894
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,36962,0.00695981799089848,0.0028969448491869,0.00128180608649216,0.0126378298953048,0.0162986724921998
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,36962,0.0039790548791905,0.00268816374818923,-0.00128974606726039,0.00924785582564138,0.138840461281619
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23557.Triglycerides in Very Large HDL,36962,-0.0044465783874435,0.00228564462534464,-0.00892644185311899,3.32850782319843e-05,0.0517437242325135
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23558.Concentration of Large HDL Particles,36962,0.00674854902979609,0.00287961935318535,0.0011044950975528,0.0123926029620394,0.0191157653960292
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23559.Total Lipids in Large HDL,36962,0.00657129181895536,0.00283610271709054,0.00101253049345791,0.0121300531444528,0.0205182674064981
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23560.Phospholipids in Large HDL,36962,0.00604354031805938,0.00277460345335172,0.000605317549490018,0.0114817630866287,0.029411626646323
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23561.Cholesterol in Large HDL,36962,0.00799503351833296,0.00290383755659337,0.00230351190740994,0.013686555129256,0.00590854392571355
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,36962,0.00828778062817079,0.00290968278883477,0.00258480236205464,0.0139907588942869,0.00440156734336763
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23563.Free Cholesterol in Large HDL,36962,0.00684244592653064,0.00286404777035771,0.00122891229662953,0.0124559795564318,0.016904577053719
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23564.Triglycerides in Large HDL,36962,-0.00511102710436005,0.00230133569032427,-0.00962164505739562,-0.000600409151324475,0.0263750426559315
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23565.Concentration of Medium HDL Particles,36962,0.00541904386312505,0.00253419582082635,0.000452020054305397,0.0103860676719447,0.0325053087281242
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23566.Total Lipids in Medium HDL,36962,0.00483088359228736,0.00249355975675453,-5.64935309515166e-05,0.00971826071552625,0.052724745002527
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23567.Phospholipids in Medium HDL,36962,0.00397078780372176,0.00245195733546196,-0.000835048573783681,0.0087766241812272,0.105377569460357
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23568.Cholesterol in Medium HDL,36962,0.00701430164577679,0.00257299311644213,0.00197123513755021,0.0120573681540034,0.00641678480491499
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,36962,0.00712805740676866,0.0025674599218511,0.00209583595994052,0.0121602788535968,0.00550582775645506
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,36962,0.00621728461165263,0.00258100781548055,0.00115850929331075,0.0112760599299945,0.016016178258028
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23571.Triglycerides in Medium HDL,36962,-0.00621494116107099,0.00233337545252431,-0.0107883570480186,-0.00164152527412335,0.00774274201686861
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23572.Concentration of Small HDL Particles,36962,0.00393331995825355,0.00231258084109372,-0.000599338490290137,0.00846597840679723,0.08899758126602
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23573.Total Lipids in Small HDL,36962,0.00240948341476617,0.00232606831177194,-0.00214961047630683,0.00696857730583917,0.300286118710745
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23574.Phospholipids in Small HDL,36962,0.00203121450828066,0.0023301516729121,-0.00253588277062706,0.00659831178718838,0.383383046272993
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23575.Cholesterol in Small HDL,36962,0.00471147596733206,0.00230929403290349,0.000185259662841213,0.00923769227182291,0.0413480784679648
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,36962,0.0049330301914582,0.00229845724122211,0.000428053998662867,0.00943800638425354,0.0318725157454185
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23577.Free Cholesterol in Small HDL,36962,0.0031883813748652,0.00235176371727705,-0.00142107551099781,0.00779783826072821,0.175205107898931
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23578.Triglycerides in Small HDL,36962,-0.00727497062366144,0.00250938921834462,-0.0121933734916169,-0.00235656775570599,0.00374856596225894
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36339,-0.00443084891794973,0.00235050802079854,-0.00903784463871487,0.000176146802815413,0.0594449363602558
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36339,0.000765461085484196,0.00234645360037277,-0.00383358797124644,0.00536451014221483,0.744263061116808
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36339,0.000864566863468088,0.00232940098316982,-0.00370105906354476,0.00543019279048094,0.710529014654523
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36339,-0.00052393714766685,0.002373149122286,-0.00517530942734742,0.00412743513201372,0.825269552405348
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36339,0.00107317919511657,0.00230060756096183,-0.00343601162436861,0.00558237001460174,0.640882659881577
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,36795,-0.000972466177004645,0.00227001024473028,-0.00542168625667599,0.0034767539026667,0.668369049782682
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,36795,0.0037218581076397,0.00254543581781643,-0.00126719609528051,0.00871091231055991,0.143719116271718
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,36795,0.00361977237887138,0.00253667687107165,-0.00135211428842904,0.00859165904617181,0.153611476884819
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,36795,0.00335816212710493,0.00243080055070524,-0.00140620695227733,0.00812253120648719,0.167147727865474
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,36795,-0.00379285218087851,0.00246978687840068,-0.00863363446254384,0.00104793010078683,0.124636386651972
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,36958,-0.00800031604804648,0.00247915817450703,-0.0128594660700803,-0.00314116602601269,0.00125390198100416
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,36958,-0.000333715437346629,0.00237768662227008,-0.00499398121699599,0.00432655034230273,0.88838325330229
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,36958,0.00115829377791925,0.00248178641277717,-0.00370600759112401,0.00602259514696251,0.640709589210719
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,36958,-0.00388870111302309,0.00232001247479024,-0.00843592556361196,0.00065852333756578,0.093731651069145
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,36958,0.00351813382810049,0.00228394848544978,-0.000958405203381087,0.00799467285958206,0.123493482820869
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,36962,0.00325360994005911,0.00250962206218373,-0.00166524930182101,0.00817246918193923,0.194841899836594
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,36962,0.00592808973326042,0.00261290542754354,0.000806795095275083,0.0110493843712458,0.0232983165631382
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,36962,0.00639080865459457,0.00262146171408703,0.00125274369498399,0.0115288736142051,0.0147868856426865
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,36962,0.00457009977691573,0.00256328554998424,-0.000453939901053386,0.00959413945488484,0.0746245869799026
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,36962,-0.00541719316269859,0.00259720420890864,-0.0105077134121595,-0.000326672913237662,0.0370179745557652
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,36962,0.0081121410372287,0.00249848819630123,0.00321510417247828,0.0130091779019791,0.00116995642806597
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,36962,0.00464538029878531,0.00240942860344091,-7.70997639588638e-05,0.00936786036152949,0.0538766111494551
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,36962,0.00200412483032514,0.00233883641689255,-0.00257999454678426,0.00658824420743453,0.391521519198172
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,36962,0.00801069080674202,0.00251696234270387,0.00307744461504245,0.0129439369984416,0.00146258577093956
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,36962,-0.00574946939927458,0.0024367510865812,-0.0105255015289737,-0.000973437269575419,0.0183150722586711
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,36962,-0.00601485053751211,0.00243952437085034,-0.0107963183043788,-0.00123338277064544,0.0136917557023399
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,36962,0.00749040750180506,0.0025620631494464,0.00246876372889013,0.01251205127472,0.00346618798293636
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,36962,0.00788084732604541,0.00259137572391684,0.00280175090716841,0.0129599437449224,0.00236116437741145
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,36962,0.00426657918570174,0.00233246797026629,-0.000305058036020196,0.00883821640742367,0.0673905206604831
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,36962,-0.00703718670547408,0.00253506211369441,-0.0120059084483151,-0.00206846496263303,0.0055120030561106
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,36962,-0.00486471490198642,0.00236205672526556,-0.00949434608350691,-0.000235083720465937,0.0394636838984933
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,36962,0.00765140050868096,0.00246389812752884,0.00282216017872444,0.0124806408386375,0.00190424374233969
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,36962,0.0085851615693529,0.00244255485306551,0.00379775405734449,0.0133725690813613,0.000441523497048237
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,36962,0.00214735279907472,0.00240443539629707,-0.00256534057766755,0.00686004617581698,0.371830816682815
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,36962,-0.00795643380017305,0.00248393192240979,-0.0128249403680962,-0.00308792723224986,0.00136253055344501
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,36962,-0.00115236320924459,0.00235430188808539,-0.00576679490989195,0.00346206849140277,0.624516261798715
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,36962,0.00936366443537686,0.00247088820125119,0.00452072356092453,0.0142066053098292,0.000151569086740931
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,36962,0.0055147816316753,0.00232375035949399,0.000960230927067078,0.0100693323362835,0.0176478763536319
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,36962,0.00662874573851955,0.00260187333727553,0.0015290739974595,0.0117284174795796,0.0108554491523778
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,36962,-0.00770467430466429,0.00240805606354413,-0.0124244641892108,-0.0029848844201178,0.00137974385333872
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,36962,0.00504870901585045,0.00233069376918253,0.000480549228252699,0.0096168688034482,0.0303151857796455
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,36962,0.00311448736686294,0.00242187421332886,-0.00163238609126163,0.00786136082498751,0.19847196555043
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,36962,-0.00413194471198147,0.00241143289189495,-0.00885835318009557,0.00059446375613263,0.0866477207582249
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,36962,0.00764574181119787,0.00252516680710301,0.00269641486927597,0.0125950687531198,0.00246806642241979
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,36962,-0.00645010738804122,0.00235119946940211,-0.0110584583480694,-0.00184175642801308,0.00609029070773134
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,36962,0.00283576262229944,0.00238217870204169,-0.00183330763370227,0.00750483287830116,0.233907961594162
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,36962,0.00249961771247759,0.00234068022801531,-0.00208811553443242,0.00708735095938761,0.285584277098911
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,36962,-0.00286172882506459,0.00238571771391605,-0.00753773554434004,0.00181427789421086,0.230345433316103
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,36962,0.00689167603238468,0.00240445460500584,0.00217894500657324,0.0116044070581961,0.00416077927284202
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,36962,-0.00724006774660571,0.00241573080526384,-0.0119749001249228,-0.00250523536828858,0.00273116094106784
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,36958,0.00145318664155495,0.00263627418707974,-0.00371391076512135,0.00662028404823125,0.581487182221679
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,36958,0.00225697521535397,0.0024186611998145,-0.00248360073628245,0.00699755116699039,0.35075940361284
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,36958,0.00727108925091939,0.0023117640923754,0.00274003162986361,0.0118021468719752,0.00166312884617469
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,36958,-0.00446332628869571,0.00278626851505453,-0.00992441257820258,0.000997760000811163,0.109201620446715
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,36958,-0.00792701091484708,0.00259104733357086,-0.013005463688646,-0.0028485581410482,0.00222240210467727
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,36962,-0.00508201792194418,0.00260915293745055,-0.0101959576793473,3.19218354588946e-05,0.0514643641295522
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,36962,0.0101761384291308,0.00265979703699632,0.00496293623661805,0.0153893406216436,0.00013089583705185
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,36962,0.00933417506167602,0.00256933380423096,0.00429828080538334,0.0143700693179687,0.000281306416165374
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,36962,0.00524383282392089,0.00261365201030762,0.000121074883717953,0.0103665907641238,0.044842201497127
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,36962,-0.0103809627234747,0.00251695474651773,-0.0153141940266494,-0.0054477314202999,3.73974095180975e-05
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,36962,-0.00855459841279073,0.00262792425985942,-0.0137053299621152,-0.00340386686346626,0.0011357287118349
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,36962,0.0101730635362203,0.00257224869074847,0.00513145610235332,0.0152146709700873,7.69599395464636e-05
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,36962,0.00896279841315951,0.00245768378605424,0.0041457381924932,0.0137798586338258,0.000266506119658388
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,36962,0.00894319359201858,0.00278201756385939,0.00349043916685418,0.014395948017183,0.00130923295798446
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,36962,-0.0103923182076426,0.00249821412396536,-0.0152888178906147,-0.00549581852467049,3.2041858039595e-05
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,36962,-0.00223347810244367,0.00232130302287506,-0.0067832320272788,0.00231627582239145,0.335984142221532
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,36962,0.00763667393480958,0.00232001031356579,0.00308945372022064,0.0121838941493985,0.000998630931250966
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,36962,0.00656583048611381,0.00227455509262031,0.002107702504578,0.0110239584676496,0.00390011049815094
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,36962,0.00260533237247875,0.00254776003192327,-0.00238827729009085,0.00759894203504836,0.306517196252226
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,36962,-0.0101571259090824,0.00255505485528464,-0.0151650334254403,-0.00514921839272454,7.06658706924524e-05
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,47194,0.00231647124790388,0.00198214227269464,-0.00156852760657762,0.00620147010238537,0.242548341511571
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,47194,0.00181900816359277,0.0019400227016934,-0.0019834363317263,0.00562145265891184,0.348448353291187
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,45482,-5.14668549157934e-05,0.0018507764132141,-0.00367898862481542,0.00357605491498383,0.977815341856785
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,45482,0.0035682304432674,0.00200514340320164,-0.000361850627007821,0.00749831151354262,0.0751655153844648
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,45482,0.00281630981351966,0.00199165211329924,-0.00108732832854686,0.00671994795558617,0.157359535609682
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,45482,4.79139618663437e-05,0.00183357262832706,-0.0035458883896547,0.00364171631338739,0.979152711376051
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24009.Traffic intensity on the nearest road,47194,0.295727704028684,0.0937024320585483,0.112070937193929,0.479384470863438,0.00160135608548197
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24010.Inverse distance to the nearest road,47194,-0.00229721738638668,0.00173842251396753,-0.00570452551376305,0.00111009074098968,0.186368354141932
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24011.Traffic intensity on the nearest major road,47194,-0.00120415518119291,0.00174999084877152,-0.00463413724478509,0.00222582688239926,0.491401516076484
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24012.Inverse distance to the nearest major road,47194,0.00243265658898082,0.0017766903305491,-0.00104965645889542,0.00591496963685706,0.170947800548703
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24013.Total traffic load on major roads,47194,0.121453703694092,0.0687269018936429,-0.0132510240174484,0.256158431405632,0.0772089719942001
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24015.Sum of road length of major roads within 100m,47194,0.116411385882035,0.0668980646737916,-0.0147088208785962,0.247531592642667,0.0818492292098972
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,47194,0.00189225033459893,0.00199164268906769,-0.00201136933597374,0.00579587000517159,0.342073677384828
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,47194,0.00219969381198533,0.00199102732527402,-0.00170271974555175,0.00610210736952242,0.269256167087227
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,47194,0.00231147004857184,0.0019713588141006,-0.00155239322706535,0.00617533332420902,0.2409977911423
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,47150,0.00124025436380904,0.00190785446785949,-0.00249914039319556,0.00497964912081365,0.515648201353108
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24020.Average daytime sound level of noise pollution,47194,0.000816729924613224,0.00173855958399363,-0.0025908468600143,0.00422430670924074,0.638520949915043
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24021.Average evening sound level of noise pollution,47194,0.000824301011089179,0.00173836773096953,-0.00258289974161111,0.00423150176378947,0.635375252658873
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24022.Average night-time sound level of noise pollution,47194,0.000809798778802919,0.00173857988548536,-0.00259781779674838,0.00421741535435422,0.641376078105447
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24023.Average 16-hour sound level of noise pollution,47194,0.00082660843555884,0.00173848740379023,-0.00258082687587001,0.00423404374698769,0.634452432916209
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24024.Average 24-hour sound level of noise pollution,47194,0.000827975370099409,0.00173857300768257,-0.00257962772495844,0.00423557846515725,0.63390894576306
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2405.Number of children fathered,34284,-0.0440044552909711,0.0759772840534511,-0.192919932035735,0.104911021453793,0.56248084415453
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44406,-0.0020785323305489,0.00203507909297154,-0.00606728735277311,0.00191022269167531,0.307099670397961
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44406,0.00135684416150284,0.00185383291937935,-0.00227666836048069,0.00499035668348637,0.464230102037952
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24502.Water percentage, buffer 1000m",44406,-0.00330111287091561,0.00180986810336143,-0.006848454353504,0.000246228611672788,0.0681738209410132
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44406,-0.00260063242952969,0.00192301781574312,-0.00636974734838621,0.00116848248932684,0.176271728128566
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44406,0.0012792810060092,0.00188266244378321,-0.00241073738380589,0.00496929939582429,0.496824767284528
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24505.Water percentage, buffer 300m",44406,-0.00304260594817054,0.00181919687970102,-0.00660823183238454,0.000523019936043468,0.0944410835751839
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",47278,-0.00202336769122564,0.00194518589074389,-0.00583593203708367,0.00178919665463239,0.298261234259398
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24507.Natural environment percentage, buffer 300m",47278,-0.00174643499598516,0.00183431839264155,-0.00534169904556259,0.00184882905359228,0.341061498968933
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24508.Distance (Euclidean) to coast,47278,-0.00238595945170785,0.00175312965459389,-0.00582209357471188,0.00105017467129618,0.173535800504062
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,27927,-0.0339229777347241,0.113050002515237,-0.255500982664589,0.187655027195141,0.764138669364024
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2704.Years since last cervical smear test,33715,0.133783456132448,0.0691973577522811,-0.00184336506202265,0.269410277326919,0.0532203781710762
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2714.Age when periods started (menarche),36538,-0.0823507006671356,0.0629194920126095,-0.20567290501185,0.040971503677579,0.190616840073828
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2734.Number of live births,36940,0.0606649403844153,0.0599995930814953,-0.0569342620553154,0.178264142824146,0.311992453370326
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2744.Birth weight of first child,33696,0.00968308466131152,0.0679734277719127,-0.123544833771637,0.14291100309426,0.886724355003042
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2754.Age at first live birth,32000,0.000842942004736201,0.00294503211305211,-0.00492932093684593,0.00661520494631833,0.774713031195908
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2764.Age at last live birth,31977,0.00381274777656414,0.00294350433343785,-0.00195652071697405,0.00958201627010233,0.19525047446642
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2794.Age started oral contraceptive pill,34994,0.00083431253607709,0.00289810333582018,-0.00484597000213047,0.00651459507428465,0.773442225064739
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2804.Age when last used oral contraceptive pill,33978,0.00208600192182665,0.00259429043228622,-0.00299880732545434,0.00717081116910764,0.421373030948093
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2867.Age started smoking in former smokers,28481,0.00495945120270436,0.00393145066263924,-0.00274619209606854,0.0126650945014773,0.207199194831896
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",34078,0.0871820172000421,0.0800331298946152,-0.0696829173934037,0.244046951793488,0.276036683597091
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,34073,0.0948164269621877,0.0891389937645252,-0.0798960008162818,0.269528854740657,0.287493441957742
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,34089,0.127905036382441,0.0911864666355998,-0.0508204382233346,0.306630510988217,0.160743936723581
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",34062,0.0833574942294208,0.0897259198881899,-0.0925053087514315,0.259220297210273,0.352898856867024
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28739.Difficulty with standing for long periods,34106,0.0564324045427821,0.0835278607236457,-0.107282202475564,0.220147011561128,0.499302428270653
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28740.Difficulty with taking care of household responsibilities,34123,0.0013460706845325,0.0947246857801501,-0.184314313444562,0.187006454813627,0.988662441151743
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28741.Difficulty learning a new task,34046,0.0671874926699866,0.105067443702014,-0.13874469698596,0.273119682325933,0.52253151932551
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28742.Difficulty with joining in community activities,33670,0.0696292993096743,0.103279007011481,-0.132797554432829,0.272056153052178,0.500208721561872
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28743.Difficulty with being emotionally affected by health problems,34051,-0.0186765661951513,0.0894217241396722,-0.193943145508909,0.156590013118606,0.834562187464364
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,34121,0.0242153847482804,0.120316583442469,-0.21160511879896,0.26003588829552,0.84049621953718
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,28355,-1.30482366268308e-05,0.10940651886173,-0.214449825205618,0.214423728732364,0.999904846553116
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2897.Age stopped smoking,28483,-0.00411219374936909,0.00473906754263486,-0.0134007661329334,0.00517637863419524,0.385591510311769
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,32954,-0.00485923803879909,0.00578753032935687,-0.0162027974843386,0.00648432140674038,0.401152098035434
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,32954,0.0017768814060425,0.00621043336210884,-0.0103955679836908,0.0139493307957758,0.774798624133282
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,32954,0.0184254508986243,0.0207078009295197,-0.0221618389232343,0.0590127407204829,0.373605910216419
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,32954,0.00731802706605721,0.0207398302836621,-0.0333320402899205,0.0479680944220349,0.724209871768314
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,32954,-0.00134582484896497,0.0220946885736838,-0.0446514144533852,0.0419597647554553,0.951430876967216
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,32954,-0.0037273713874258,0.018755076161028,-0.0404873206630407,0.0330325778881891,0.842471094594618
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,32954,0.00023193278142638,0.00862639522710623,-0.0166758018637018,0.0171396674265546,0.978550924405901
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,32954,0.0242769229577171,0.0155419881752782,-0.00618537386582815,0.0547392197812623,0.118317670564919
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29002.Recent lack of interest or pleasure in doing things,32899,-0.0298563234690908,0.0943314301197168,-0.214745926503736,0.155033279565554,0.751626909628157
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29003.Recent feelings of depression,32898,-0.0646703147284928,0.0921888089188363,-0.245360380209412,0.116019750752426,0.48301001231488
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",32904,-0.000623055523109772,0.0747282715851064,-0.147090467829918,0.145844356783699,0.993347807101302
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29005.Recent feelings of tiredness or low energy,32910,-0.109317312033918,0.0766941701804308,-0.259637885587562,0.0410032615197268,0.15408573936912
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29006.Recent poor appetite or overeating,32915,-0.0616108088099732,0.100897013149625,-0.259368954583238,0.136147336963292,0.541459455492672
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29007.Recent feelings of inadequacy,32883,0.0282691460466627,0.0964273229956481,-0.160728407024808,0.217266699118133,0.769402541634977
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29008.Recent trouble concentrating on things,32914,-0.0981781414275,0.0986951635223036,-0.291620661931215,0.095264379076215,0.319878902178159
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29009.Recent changes in speed or amount of moving or speaking,32903,-0.0479318339470209,0.177876875492584,-0.396570509912486,0.300706842018444,0.787576976339456
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29010.Recent thoughts of suicide or self-harm,32851,-0.155596531686949,0.194943363564913,-0.537685524274177,0.22649246090028,0.424797134524682
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#0.Substances taken for depression_None of options listed,31326,0.00367112096528504,0.0107821079548794,-0.0174618106262787,0.0248040525568487,0.733502646631755
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31326,-0.00101662771643351,0.0189105348338678,-0.0380812759908144,0.0360480205579473,0.95712792821537
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31326,0.00155289819733308,0.0106979939290308,-0.0194151699035672,0.0225209662982334,0.884590133117402
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31326,-0.0086497489546582,0.0313921408877391,-0.0701783450946268,0.0528788471853104,0.782910041096949
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31326,0.0257823777869943,0.0183708025963737,-0.0102243953018981,0.0617891508758867,0.160526310187918
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31326,-0.0013206845772859,0.0199958569352526,-0.0405125641703811,0.0378711950158093,0.947341449741934
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31326,-0.00362934304553535,0.0231602883328246,-0.0490235081778716,0.0417648220868009,0.87548124105188
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31326,0.00437168832826763,0.0269018204341887,-0.0483558797227422,0.0570992563792775,0.870912354884892
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31326,0.0103159740083088,0.0215297171851297,-0.0318822716745455,0.052514219691163,0.631845623843965
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31326,0.00733554449408854,0.0109088376973152,-0.0140457773926493,0.0287168663808264,0.501324103953038
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31326,-0.018711653175813,0.0160485458064309,-0.0501668029564176,0.0127434966047916,0.24367565544793
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31326,0.048756959983366,0.0250655054266492,-0.00037143065286642,0.0978853506195983,0.0517906151763558
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31326,0.0113246722559374,0.030540536593837,-0.0485347794679832,0.0711841239798579,0.710791136701064
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31326,0.0187504951873455,0.0198895978451591,-0.0202331165891664,0.0577341069638573,0.345850180966099
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31326,0.0225947092895271,0.0316104341259529,-0.0393617415973406,0.0845511601763947,0.474763371677696
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31326,0.0147339092917483,0.0303512406466741,-0.0447545223757329,0.0742223409592295,0.627373764565143
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31326,0.0194652100565481,0.0165232401796096,-0.0129203406954868,0.0518507608085829,0.238814053086417
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31326,0.0115631039919933,0.0163183509607374,-0.0204208638910521,0.0435470718750387,0.478597883636057
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31326,-0.00931237960504696,0.0231232674017742,-0.0546339837125245,0.0360092245024305,0.687160106627231
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29058.Recent feelings or nervousness or anxiety,32767,0.0332714685992286,0.0855888284332999,-0.134482635130039,0.201025572328496,0.697480657978606
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29059.Recent inability to stop or control worrying,32769,-0.125516137675315,0.0918012264713258,-0.305446541559113,0.0544142662084838,0.171578351278505
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29060.Recent worrying too much about different things,32764,0.00249591228152896,0.082929208983535,-0.1600453373262,0.165037161889258,0.975990446093901
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29061.Recent trouble relaxing,32769,-0.0179173413717963,0.0872073397985315,-0.188843727376918,0.153009044633325,0.837219938281925
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29062.Recent restlessness,32771,0.0775923893721829,0.121355914490666,-0.160265203029523,0.315449981773889,0.522593027697284
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29063.Recent easy annoyance or irritability,32758,0.0534268648062421,0.0880022101673851,-0.119057467121833,0.225911196734317,0.543794592640681
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29064.Recent feelings of foreboding,32752,0.0454597141409812,0.0996695241003126,-0.149892553095632,0.240811981377594,0.648326006926714
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31326,0.0118195643900836,0.0110529821663175,-0.00984428065589882,0.0334834094360659,0.284944199587013
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31326,-0.00621676403217258,0.0176927389043617,-0.0408945322847215,0.0284610042203763,0.725317887497288
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31326,0.051826172826644,0.0237729293552259,0.0052312312904012,0.0984211143628869,0.0292848900345708
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31326,0.0257849173045611,0.0265282895631792,-0.0262105302392702,0.0777803648483924,0.331092916539851
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#2.Symptoms of panic attack_Sweating,31326,-0.0181303749944551,0.0167058992679457,-0.0508739375596286,0.0146131875707183,0.277838092032319
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31326,0.0284482765444589,0.0178778409998831,-0.00659229181531194,0.0634888449042297,0.111593622147552
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31326,0.0306444208186926,0.0178479032457822,-0.00433746954304048,0.0656263111804257,0.0860250389624904
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31326,0.00389259348110274,0.0165692511915441,-0.0285831388543237,0.0363683258165292,0.814270476893472
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31326,-0.0328922462445548,0.0217929405974336,-0.0756064098155247,0.00982191732641497,0.13126256370763
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29076.Felt loved as a child,32731,-0.0890632842562066,0.0786745329992896,-0.243265368934814,0.065138800422401,0.257645203190294
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29077.Physically abused by family as a child,32734,0.0295029335787597,0.0993865357708583,-0.165294676532123,0.224300543689642,0.766587669841187
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29078.Felt hated by family member as a child,32721,-0.0289222916603063,0.103593320407652,-0.231965199659305,0.174120616338692,0.780104998109257
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29079.Sexually molested as a child,32662,0.105154263407369,0.137317095859947,-0.163987244478126,0.374295771292865,0.443829587249564
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29080.Someone to take to doctor when needed as a child,32722,0.191056741350466,0.120096915695525,-0.0443332134127631,0.426446696113696,0.11167796280148
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32718,-0.16310859888743,0.145116631550159,-0.447537196725741,0.121319998950881,0.261050781808631
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32673,-0.0421930791925503,0.111028076785888,-0.259808109692891,0.17542195130779,0.703938461079991
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32725,-0.106412860863463,0.124701820521121,-0.350828429084859,0.138002707357934,0.393494690029301
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32694,-0.107638911789953,0.178493809665984,-0.457486778735282,0.242208955155376,0.546497544435463
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32693,0.0154446925430161,0.169828477794997,-0.317419123935178,0.348308509021211,0.927540032592643
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29086.Experienced a violent or sexual assault,32727,0.0691930522065856,0.135201084273053,-0.195801072968598,0.334187177381769,0.608818557117604
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29087.Experienced a life-threatening injury or illness,32734,0.155336048865512,0.0932751869820671,-0.0274833176193395,0.338155415350363,0.0958777891371449
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29088.Experienced a marital separation or divorce,32735,-0.0412619112043866,0.0854341039793534,-0.208712755003919,0.126188932595146,0.629130597528811
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29089.Experienced the death of a spouse or partner,32744,-0.0579355403418833,0.136880806040383,-0.326221920181034,0.210350839497267,0.672119177231963
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32733,0.237000280886443,0.101723017602279,0.0376231663859767,0.43637739538691,0.0198359250311919
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29091.Frequency of drinking alcohol,32739,0.0462492285860226,0.0712481428825282,-0.0933971314637327,0.185895588635778,0.516271859077524
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31825,0.0737602337831404,0.0800442759969377,-0.0831265471708575,0.230647014737138,0.356821055078306
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31835,0.0927771637171437,0.0789684235708583,-0.0620009464817385,0.247555273916026,0.240084191743122
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29104.Ever used cannabis,32728,0.0962790178363863,0.0921199969208592,-0.0842761761284978,0.27683421180127,0.295983133180339
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29108.Ever thought that life not worth living,32690,0.094658831852588,0.0847037474422277,-0.0713605131341783,0.260678176839354,0.263798929701553
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29109.Ever contemplated self-harm,32701,0.0471557696751147,0.112831304774038,-0.173993587682,0.26830512703223,0.676007266267374
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29111.Ever self-harmed,32721,0.188943223444401,0.174280639418929,-0.152646829816699,0.530533276705501,0.278335762878728
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32728,-0.0611333849603337,0.121902125295189,-0.300061550538903,0.177794780618236,0.616034792316144
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,31860,0.00082898941627562,0.0233616700887438,-0.0449598839576622,0.0466178627902135,0.971693873550456
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,31860,-0.00657674977272046,0.0187798249449175,-0.0433852066647587,0.0302317071193178,0.726195625532984
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,31860,0.00111200926201459,0.0192953273575021,-0.0367068323586896,0.0389308508827188,0.954043985231032
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,31860,0.0131152740090538,0.0258294926786397,-0.0375105316410799,0.0637410796591876,0.611633197399244
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32718,0.0687357682841971,0.0784963665760939,-0.0851171102049471,0.222588646773341,0.38124113744013
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X29153.Pain or discomfort today,32730,-0.0388471483707494,0.0752543071805656,-0.186345590444658,0.108651293703159,0.605719482580701
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29154.Anxiety or depression today,32730,-0.0707710285991426,0.0934795501699281,-0.253990946932202,0.112448889733917,0.44902505874318
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29166.Frequency of confiding in someone close,32533,-0.067609974464616,0.0732147805623802,-0.211110944366881,0.0758909954376492,0.35579997397905
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32701,0.00484220779322746,0.00603788859022037,-0.00699205384360446,0.0166764694300594,0.422591648530921
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32701,0.0131044917062121,0.00601270003695896,0.00131959963377255,0.0248893837786517,0.0293231670231059
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32701,-0.0152656874997541,0.00752681746052822,-0.0300182497223894,-0.000513125277118817,0.0425725229500644
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32701,-0.00885670079624647,0.00885994286068879,-0.0262221888031965,0.00850878721070356,0.317514984350765
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32701,-0.0125682311775341,0.0137298688683259,-0.0394787741594529,0.0143423118043846,0.360010114429334
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32701,-0.00539607866901257,0.0064703047645832,-0.0180778760075956,0.0072857186695705,0.404317058866197
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32698,0.0011521082511109,0.00706449341902258,-0.0126942988501734,0.0149985153523952,0.870455757791122
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32698,0.00306773083140338,0.0100222141841525,-0.0165758089695356,0.0227112706323424,0.759540954229994
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32698,-0.0184387408624097,0.0162753515745754,-0.0503384299485774,0.0134609482237581,0.257276788475187
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32698,0.00103144130110996,0.0158185326818986,-0.0299728827554114,0.0320357653576313,0.948012563084031
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32698,-0.0187053391329207,0.0215496341229827,-0.0609426220139667,0.0235319437481253,0.385411379286852
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32698,-0.00666338683349147,0.0104885496828721,-0.0272209442119207,0.0138941705449377,0.525248523575432
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29171.Frequency of feeling 'in tune' with people,32541,0.0963552773784678,0.0915945007194186,-0.0831699440315927,0.275880498788528,0.292839540577059
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29172.Freuency of feeling that lacks companionship,32658,0.0196714162478883,0.0827511592653691,-0.142520855912235,0.181863688408012,0.812105581294207
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29173.Frequency of feeling left out,32613,0.117123591315512,0.0841217159816112,-0.0477549720084461,0.28200215463947,0.163863612723232
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29174.Frequency of feeling isolated from others,32641,-0.032122146516958,0.0883039071651263,-0.205197804560606,0.14095351152669,0.716039927432787
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29175.Tendency to bounce back quickly after hard times,32715,0.110094569719221,0.0730568377678527,-0.0330968323057702,0.253285971744212,0.131853656201374
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29176.Ability to make it through stressful events,32715,-0.0432659505027187,0.0722428999698548,-0.184862034443634,0.0983301334381967,0.549257871972114
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29177.Quick recovery from stressful events,32715,0.152327615570282,0.0732861156504917,0.00868682889531858,0.295968402245246,0.0376890233359669
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29178.Hard to snap back when something bad happens,32715,-0.12650464396676,0.0724938510696941,-0.26859259206336,0.0155833041298404,0.0810126688455525
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29179.Comes through difficult times with little trouble,32715,0.108210335789802,0.0726924901944359,-0.0342669449912924,0.250687616570896,0.136627285750654
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29180.Tendency to take a long time to get over setbacks,32715,-0.116305840622076,0.0728151823999373,-0.259023598125953,0.0264119168818015,0.110240206072173
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29181.General happiness,32659,-0.0224201896075942,0.075530047314723,-0.170459082344451,0.125618703129263,0.766597187757864
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29182.Belief that own life is meaningful,32578,-0.0500864359092496,0.0754925653480892,-0.198051863991504,0.0978789921730051,0.507052363889247
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28082,-0.216779331149545,0.104592831428008,-0.42178128074844,-0.0117773815506496,0.0382698759045536
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2946.Father's age,32382,0.00881206945709528,0.00441929175755272,0.000150257612291942,0.0174738813018986,0.0461838242491383
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2966.Age high blood pressure diagnosed,28246,-0.00461009812181878,0.00642689399820136,-0.0172068103582934,0.00798661411465588,0.473218849866555
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30000.White blood cell (leukocyte) count,46780,-0.0022891161822283,0.00181660567989408,-0.00584966331482069,0.00127143095036409,0.207643863175473
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,46780,7.35252065810778e-05,0.0021473549003293,-0.00413529039806436,0.00428234081122651,0.972686151631225
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30020.Haemoglobin concentration,46780,-0.00331202702400737,0.00229042808606454,-0.00780126607269386,0.00117721202467912,0.148182547027813
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30030.Haematocrit percentage,46780,-0.00282560161131925,0.00224530755787286,-0.00722640442475006,0.00157520120211156,0.208242792779397
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30040.Mean corpuscular volume,46780,-0.00319212415876164,0.00181309722322675,-0.00674579471628608,0.000361546398762793,0.0783208472129968
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30050.Mean corpuscular haemoglobin,46779,-0.00299472639557212,0.00181940007319218,-0.00656075053902879,0.000571297747884549,0.0997781636417435
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,46779,-0.000574900130335265,0.00178098406615877,-0.00406562890000646,0.00291582863933593,0.746850306704801
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,46780,0.00204565452921656,0.00173091122481095,-0.0013469314714129,0.00543824052984603,0.237282736642751
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30080.Platelet count,46780,0.000178833382005682,0.0018350382130578,-0.0034178415155876,0.00377550827959896,0.922366036560819
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30090.Platelet crit,46780,0.00111027974076462,0.00187984130204564,-0.00257420921124484,0.00479476869277408,0.554778078616006
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,46780,0.000942662871158635,0.00176510696544761,-0.00251694678111867,0.00440227252343594,0.59330918277811
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30110.Platelet distribution width,46780,-5.69436862052358e-05,0.00175070844417872,-0.00348833223679552,0.00337444486438505,0.974052799917305
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30120.Lymphocyte count,46748,-0.000490481176487504,0.00185169240634629,-0.00411979829292624,0.00313883593995123,0.791102255925176
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30130.Monocyte count,46748,-0.00246912052976966,0.00185089221022953,-0.00609686926181954,0.00115862820228023,0.182211760936414
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30140.Neutrophill count,46748,-0.00295700951749121,0.00180355768425761,-0.00649198257863614,0.000577963543653707,0.101114065109287
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30150.Eosinophill count,46748,0.00234517135626253,0.0017621263919244,-0.0011085963719093,0.00579893908443436,0.183243141541662
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30160.Basophill count,46748,-0.0154782801606952,0.0514314001960047,-0.116283824544864,0.085327264223474,0.763455351922731
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30170.Nucleated red blood cell count,46748,0.216249594034711,0.223418550066391,-0.221650764095416,0.654149952164838,0.333098328592876
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30180.Lymphocyte percentage,46748,0.0017311724965649,0.00182255530865162,-0.00184103590839227,0.00530338090152207,0.342193392276873
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30190.Monocyte percentage,46748,-0.000676009004747892,0.00182711773386565,-0.00425715976312457,0.00290514175362879,0.711395927982588
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30200.Neutrophill percentage,46748,-0.00230310367857983,0.00179421434699917,-0.00581976379869821,0.00121355644153855,0.199285161553613
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30210.Eosinophill percentage,46748,0.00275141683105773,0.00173779496935211,-0.000654661308872403,0.00615749497098787,0.1133713693297
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30220.Basophill percentage,46748,0.00136212170731997,0.00173588671231531,-0.00204021624881803,0.00476445966345797,0.432647264969198
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30230.Nucleated red blood cell percentage,46748,0.213633628676527,0.22312316336746,-0.223687771523695,0.650955028876748,0.338340436076954
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30240.Reticulocyte percentage,46364,-0.00213684502154105,0.00186365680250372,-0.00578961235444834,0.00151592231136625,0.25156446295611
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30250.Reticulocyte count,46364,-0.00209448019861772,0.00191287850125047,-0.00584372206106864,0.0016547616638332,0.273556242405802
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30260.Mean reticulocyte volume,46364,-0.00172529122463978,0.00180053577951885,-0.00525434135249672,0.00180375890321716,0.337967215808701
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30270.Mean sphered cell volume,46364,-0.00138668363229392,0.00180739057393594,-0.00492916915720836,0.00215580189262052,0.442953037919269
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30280.Immature reticulocyte fraction,46364,-0.00172913905952117,0.00188034064127114,-0.0054146067164126,0.00195632859737027,0.35779785372172
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30290.High light scatter reticulocyte percentage,46364,-0.00238552807648621,0.00190464918051884,-0.00611864047030314,0.00134758431733071,0.210409351852094
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30300.High light scatter reticulocyte count,46364,-0.00231419285751541,0.00193839937453187,-0.00611345563159787,0.00148506991656705,0.232542216882406
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30500.Microalbumin in urine,30743,-0.00259120657703995,0.00315852218309694,-0.00878191005590995,0.00359949690183005,0.412024648286969
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,46897,-0.00197301974700396,0.00185747921433797,-0.00561367900710639,0.00166763951309847,0.288154733358787
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30520.Potassium in urine,46848,-0.00122823263892595,0.00172355453031833,-0.00460639951834987,0.00214993424049797,0.476090603802636
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30530.Sodium in urine,46846,0.000249679563553565,0.00179542358663974,-0.00326935066626033,0.00376870979336746,0.889400451510537
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30600.Albumin,44530,0.00377868555008817,0.00192592551943917,3.87153198739805e-06,0.00755349956818894,0.0497746925211938
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30610.Alkaline phosphatase,46436,-0.00143099619854666,0.00181627644082083,-0.0049908980225555,0.00212890562546217,0.430778935792802
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30620.Alanine aminotransferase,46426,-0.00384506309166177,0.00192009620985183,-0.00760845166297135,-8.1674520352194e-05,0.0452389839881596
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30630.Apolipoprotein A,44403,0.00290150898087729,0.00209934783386459,-0.00121321277349731,0.0070162307352519,0.166955976037641
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30640.Apolipoprotein B,46289,0.00240735904994904,0.00184950409213026,-0.00121766897062627,0.00603238707052434,0.193058294974775
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30650.Aspartate aminotransferase,46362,-0.000152999516334417,0.00179674074898176,-0.00367461138433866,0.00336861235166983,0.932139782281825
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30660.Direct bilirubin,42876,-0.000829342272221446,0.00196876161741464,-0.00468811504235415,0.00302943049791126,0.673576763653736
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30670.Urea,46431,-0.0014611653765064,0.00189258847809612,-0.00517063879357479,0.002248308040562,0.440095262669962
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30680.Calcium,44528,0.000976381371928842,0.00187302580190719,-0.00269474919980924,0.00464751194366693,0.602173418724346
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30690.Cholesterol,46441,0.00333189971203471,0.00189911042515306,-0.000390356721265295,0.00705415614533471,0.0793665033827819
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30700.Creatinine,46435,0.00313011020385346,0.00230701113355277,-0.00139163161790996,0.00765185202561689,0.174864189514898
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30710.C-reactive protein,46367,-0.00796024455155625,0.0019685023233608,-0.0118185091053434,-0.00410197999776909,5.27652206335111e-05
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30720.Cystatin C,46437,-0.00169296185850507,0.00212606882452543,-0.00586005675457492,0.00247413303756478,0.425873368633278
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30730.Gamma glutamyltransferase,46432,-0.0028001243067014,0.00196060598471454,-0.0066429120367419,0.0010426634233391,0.153250068002162
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30740.Glucose,44495,0.000896418640217086,0.0019088381647345,-0.00284490416266253,0.0046377414430967,0.638635215857663
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46269,-0.000586822830194078,0.00192440735798199,-0.00435866125183877,0.00318501559145062,0.760417036769492
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30760.HDL cholesterol,44509,0.00563249086256536,0.00221408404519533,0.00129288613398251,0.00997209559114821,0.0109682997021909
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30770.IGF-1,46333,-0.00107255236209398,0.00186794301784709,-0.00473372067707428,0.00258861595288632,0.565845648669527
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30780.LDL direct,46391,0.00253719233244495,0.00187746701984602,-0.00114264302645326,0.00621702769134315,0.176583732434038
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30790.Lipoprotein A,41959,-0.00241311481148639,0.00199440080288726,-0.00632214038514542,0.00149591076217264,0.226315890650507
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30810.Phosphate,44478,0.000393475317089426,0.00186706541833906,-0.00326597290285514,0.00405292353703399,0.833088083571153
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30830.SHBG,44334,0.00115498591911134,0.00217023749711767,-0.00309867957523929,0.00540865141346198,0.594597877475184
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30840.Total bilirubin,46355,-0.00145128591071058,0.00183801107304445,-0.00505378761387769,0.00215121579245654,0.429772156693819
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30850.Testosterone,44620,0.00268171020153929,0.00308402560915434,-0.00336297999240321,0.00872640039548179,0.384557181973977
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30860.Total protein,44513,-0.000790724356303949,0.00190773546894515,-0.00452988587543644,0.00294843716282854,0.678524551983858
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30870.Triglycerides,46423,-0.00269548924859989,0.0018780062236731,-0.00637638144699917,0.000985402949799395,0.151217473851208
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30880.Urate,46417,-9.22688032490074e-05,0.00227413298055411,-0.00454956944513507,0.00436503183863705,0.967636526117153
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30890.Vitamin D,45514,0.000286063714553771,0.00196885534937493,-0.0035728927702211,0.00414502019932864,0.884479765065475
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3137.Number of measurements made,45593,-0.0361011882751492,0.0571844726136031,-0.148182754597811,0.0759803780475129,0.527843816461738
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3143.Ankle spacing width,37199,-8.5208934761309e-05,0.00325619901767783,-0.00646735900940986,0.00629694113988724,0.979123554800161
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37198,0.000708473917767298,0.00248610882774464,-0.0041642993846122,0.00558124722014679,0.775669243747213
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3146.Speed of sound through heel,37199,0.00118165772327459,0.00242064342521674,-0.00356280339015022,0.0059261188366994,0.625445583678413
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37199,0.00110834890144087,0.00244233591070096,-0.00367862948353302,0.00589532728641476,0.649975195986849
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3148.Heel bone mineral density (BMD),37189,0.00126515527386796,0.00244879954905848,-0.00353449184228665,0.00606480239002258,0.605413927685191
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X3526.Mother's age at death,33450,-0.000645118308798262,0.00320330202255062,-0.00692359027299747,0.00563335365540094,0.840396607973723
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X3581.Age at menopause (last menstrual period),29342,-0.00107547503742371,0.00459309110334146,-0.010077933599973,0.00792698352512555,0.814876806742882
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29276,0.00831479379664713,0.00427385202176854,-6.19561660191986e-05,0.0166915437593135,0.0517660870694509
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4100.Ankle spacing width (left),31439,0.00264185796646416,0.00426304008001321,-0.00571370059036173,0.0109974165232901,0.535465908690578
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4101.Heel broadband ultrasound attenuation (left),31439,0.00383246862646433,0.00324620455382796,-0.00253009229903847,0.0101950295519671,0.237798770707099
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4103.Speed of sound through heel (left),31439,0.00286275221030937,0.00317819897018074,-0.00336651777124488,0.00909202219186363,0.367751637044235
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",31439,0.00341491692393609,0.00320278431379912,-0.00286254033111019,0.00969237417898237,0.286351925418302
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4105.Heel bone mineral density (BMD) (left),31433,0.00341703897216341,0.00320697579050553,-0.00286863357722743,0.00970271152155425,0.286682810720537
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",31439,0.00342091640932337,0.00320282163603934,-0.00285661399731373,0.00969844681596047,0.285511872084389
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4119.Ankle spacing width (right),31428,0.00219385852884235,0.00419193976235107,-0.00602234340536574,0.0104100604630504,0.600744897420614
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4120.Heel broadband ultrasound attenuation (right),31428,0.000901085652799893,0.0032815186761101,-0.0055306909523759,0.00733286225797569,0.783635598261985
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4122.Speed of sound through heel (right),31428,0.00105351866262581,0.00319291158051928,-0.00520458803519199,0.0073116253604436,0.741442736658998
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",31428,0.00120715439401313,0.0032254167790012,-0.00511466249282922,0.00752897128085548,0.708219088157571
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4124.Heel bone mineral density (BMD) (right),31421,0.0015725944176781,0.00323176195997842,-0.0047616590238796,0.0079068478592358,0.626551750043368
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",31428,0.00120712915822441,0.0032254388429868,-0.00511473097402973,0.00752898929047854,0.708226812800589
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4194.Pulse rate,31700,0.00326255518853111,0.00308364832434877,-0.00278139552719248,0.00930650590425469,0.290079869581634
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4195.Pulse wave reflection index,31700,-0.00274182507288927,0.00299043945413018,-0.00860308640298442,0.00311943625720588,0.359242324163987
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4196.Pulse wave peak to peak time,31695,0.00106652722781379,0.00320395662934273,-0.00521322776569797,0.00734628222132555,0.739235152755505
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4198.Position of the pulse wave peak,31700,-0.00325301443806712,0.00307842491541991,-0.00928672727229013,0.00278069839615589,0.290674732943749
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4199.Position of pulse wave notch,31700,0.000675733401226826,0.0030383628662221,-0.00527945781656849,0.00663092461902214,0.824007920797106
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4200.Position of the shoulder on the pulse waveform,31700,-0.00443394362402581,0.00315281232092889,-0.0106134557730464,0.00174556852499482,0.159661169718918
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4269.Number of triplets attempted (left),31569,-0.419116271014816,0.248240653092817,-0.905667951076737,0.0674354090471054,0.0913852280923038
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4270.Volume level set by participant (left),31492,-0.0935031726301078,0.0804788591467007,-0.251241736557641,0.0642353912974256,0.245338753432678
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4276.Number of triplets attempted (right),31578,0.124702793825378,0.280835080754492,-0.425733964453426,0.675139552104183,0.657024114747294
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4277.Volume level set by participant (right),31495,-0.0871681108176387,0.0801251055840074,-0.244213317762293,0.0698770961270158,0.276673563354825
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X4288.Time to answer,31722,-0.00851580353127677,0.00349928651396604,-0.0153744050986502,-0.00165720196390333,0.0149723430129707
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X4290.Duration screen displayed,31722,-0.00964255341259775,0.0030607166656738,-0.0156415580773184,-0.00364354874787711,0.00163645481547545
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X46.Hand grip strength (left),47481,0.0085123288417581,0.00247153284489181,0.00366812446577014,0.013356533217746,0.000573852631785889
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X47.Hand grip strength (right),47464,0.00392723052796886,0.00245919629515103,-0.000892794210527163,0.00874725526646488,0.110288697986224
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X48.Waist circumference,47531,-0.00203289281534141,0.00387740868974685,-0.00963261384724523,0.0055668282165624,0.600080645971875
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X4803.Tinnitus,31528,-0.16280271083282,0.101368432815072,-0.361484839150361,0.0358794174847208,0.108304248764964
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X4825.Noisy workplace,31654,-0.0193143189449607,0.112445826366581,-0.239708138623459,0.201079500733537,0.863626312398896
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X4836.Loud music exposure frequency,31600,-0.128930931950809,0.120946957965263,-0.365986969562725,0.108125105661107,0.286451389427711
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X49.Hip circumference,47528,-0.00210407326448581,0.00306779435874863,-0.00811695020763311,0.0039088036786615,0.49280897226588
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X50.Standing height,47502,0.00378017636992163,0.00243404993872165,-0.000990561509972804,0.00855091424981606,0.120427017844146
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X5057.Number of older siblings,31000,-0.0829823205095061,0.084647277464779,-0.248890984340473,0.0829263433214608,0.326956150143476
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X51.Seated height,47389,0.00022063285931871,0.00225621627915883,-0.00420155104783261,0.00464281676647003,0.922100771775806
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5181.Ever had eye surgery,29186,-0.193409517642866,0.219228547530538,-0.62309747080272,0.236278435516988,0.377693464513872
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5186.Duration visual-acuity screen displayed (right),29175,0.00129735280007726,0.00373373450287062,-0.00602076682554916,0.00861547242570368,0.728253605873148
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5188.Duration visual-acuity screen displayed (left),29174,0.00353514434157122,0.00369437553690827,-0.003705831710769,0.0107761203939114,0.338661754585392
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5190.Duration at which refractometer first shown (right),29123,0.00390149731872464,0.00365038440189668,-0.00325325610899285,0.0110562507464421,0.285212956634405
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5193.Duration at which refractometer first shown (left),29122,0.00281093424767288,0.00367343801342093,-0.00438900425863214,0.0100108727539779,0.444183620249057
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5199.logMAR, initial (right)",29151,0.00463892482974802,0.0998994588867354,-0.191164014588253,0.200441864247749,0.962964547815998
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5200.Final number of letters displayed (right),29151,0.391331676428654,0.772913932824033,-1.12357963190645,1.90624298476376,0.612662305908061
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5201.logMAR, final (right)",29108,-0.00026725221320706,0.00353498048085891,-0.00719581395569052,0.0066613095292764,0.93973848762806
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5202.Number of rounds to result (right),29151,0.021057290087846,0.0968353719244015,-0.168740038883981,0.210854619059673,0.827862542902633
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5206.logMAR, initial (left)",29151,-0.116085618011911,0.100140540911577,-0.312361078198602,0.0801898421747798,0.246415994397017
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5207.Final number of letters displayed (left),29151,-0.583116931059071,0.600157964955543,-1.75942654237193,0.593192680253792,0.331291150692312
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5208.logMAR, final (left)",29110,-0.00533277520763129,0.00356878114924576,-0.012327586260153,0.0016620358448904,0.135161310619951
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5209.Number of rounds to result (left),29147,0.145154760819777,0.097779238086728,-0.0464925458302097,0.336802067469764,0.137732044905406
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",28944,0.0017166766430983,0.00365586458707465,-0.00544881794756801,0.00888217123376461,0.638683903703598
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",28944,-0.00141735970914323,0.00359045487671223,-0.00845465126749919,0.00561993184921274,0.693038274862409
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5256.Corneal hysteresis (right),28944,-0.00403438746018945,0.00367079762831194,-0.0112291508116808,0.00316037589130195,0.271798617212426
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5257.Corneal resistance factor (right),28944,-0.00395527895687751,0.00359582459138862,-0.0110030951559992,0.0030925372422442,0.271399723888553
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",28922,-0.000971571977740367,0.00371667521019542,-0.00825625538972338,0.00631311143424265,0.793787829466887
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",28922,-0.00559308781452205,0.00364363826444968,-0.0127346188128434,0.00154844318379933,0.124839375488881
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5264.Corneal hysteresis (left),28922,-0.00573201997365927,0.00370008300029716,-0.0129841826542417,0.00152014270692316,0.121405815427522
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5265.Corneal resistance factor (left),28922,-0.00747490582967193,0.00363698489612544,-0.0146033962260778,-0.000346415433266065,0.0399062565519841
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29005,0.318937740039391,0.424565334165662,-0.513210314925307,1.15108579500409,0.452560625521905
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",47456,-0.0119017737065253,0.0104351586000966,-0.0323546845627147,0.00855113714966405,0.254070663194028
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",47456,-0.00772178655563891,0.0115040834446302,-0.030269790107114,0.0148262169958362,0.502086092674023
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",47456,0.00231108828760497,0.0286409772164739,-0.0538252270566839,0.0584474036318939,0.93568784577817
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",47456,-0.000988441226315458,0.00484698586136195,-0.0104885335145849,0.00851165106195397,0.838410701434802
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",47456,0.000687456217178515,0.00434879167195703,-0.00783617545985726,0.00921108789421429,0.874395252434067
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35624,-0.00608450116855715,0.00489879102491114,-0.015686131577383,0.00351712924026869,0.214246054937281
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35624,-0.0106953707603505,0.0169699978817347,-0.0439565666085505,0.0225658250878495,0.528542131481757
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35624,0.000780767354568462,0.00837800608078312,-0.0156401245637664,0.0172016592729034,0.925752217401646
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35624,-0.00335472889829096,0.00529680603682719,-0.0137364687304723,0.00702701093389033,0.526517815918495
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,47520,0.00730386846039643,0.00973142732982713,-0.0117697291060647,0.0263774660268576,0.452934346338312
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,47520,0.00730386846039643,0.00973142732982713,-0.0117697291060647,0.0263774660268576,0.452934346338312
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),47520,-0.00160757198248307,0.00721591148120921,-0.0157507584856531,0.012535614520687,0.823707447127856
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',47520,-0.00415364107076286,0.0112177227704575,-0.0261403777008595,0.0178330955593337,0.711180995291365
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),47520,0.0131739024637665,0.027265152913341,-0.0402657972463818,0.0666136021739149,0.628974335847766
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),47520,0.00500155400986709,0.019492750089334,-0.0332042361652276,0.0432073441849617,0.797501120154557
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,47520,0.0453086017645037,0.0300831912181946,-0.0136544530231578,0.104271656552165,0.132052231244393
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,47455,-0.00132336105110035,0.00557054396931183,-0.0122416272309515,0.00959490512875084,0.812221289843582
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,47455,0.00429616035463615,0.00953228194698428,-0.014387112261453,0.0229794329707253,0.652212881879717
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,47455,0.00647456530525716,0.0046688252492473,-0.00267633218326754,0.0156254627937819,0.165526412461154
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,47455,0.0164277920507245,0.00870722574618924,-0.000638370411806369,0.0334939545132554,0.0592149757274681
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,47455,-0.013008630843793,0.00756737653077007,-0.0278406888441023,0.00182342715651633,0.0856200151158016
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,47455,-0.00615114800419086,0.00614669546899659,-0.0181986711234242,0.00589637511504244,0.316970340445994
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,29125,-0.00499694352298512,0.0154984564793307,-0.0353739182224733,0.025380031176503,0.747150699592754
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,29125,-0.0294309587635877,0.013638659497708,-0.0561627313790954,-0.00269918614807995,0.0309801432816515
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,29125,0.0276843172189845,0.0168495524913103,-0.00534080566398373,0.0607094401019528,0.100436476320496
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,29125,-0.0148719077464993,0.0139395820467641,-0.042193488558157,0.0124496730651585,0.286073440142003
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,47415,0.00755797828579576,0.0152873459631781,-0.0224052198020334,0.0375211763736249,0.621032276417447
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#2.Fractured bone site(s)_Leg,47415,0.0520188102270609,0.0222579029607454,0.00839332042400003,0.0956443000301218,0.0194426329887896
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#3.Fractured bone site(s)_Hip,47415,-0.0305937348674548,0.0467636225144438,-0.122250434995765,0.061062965260855,0.512975945312538
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#4.Fractured bone site(s)_Spine,47415,0.0377464148252602,0.0374079942269551,-0.0355732538595718,0.111066083510092,0.312962581270607
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,47415,-9.90993218782806e-06,0.0141734751862396,-0.0277899212972175,0.0277701014328419,0.999442134182116
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#6.Fractured bone site(s)_Arm,47415,-0.0260219081425455,0.0180238446982839,-0.0613486437511819,0.0093048274660909,0.148822886050372
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,47415,0.00136579446449358,0.00741582696578155,-0.0131692263884382,0.0159008153174254,0.853879392638839
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32047,-0.0149400579165816,0.0141927619672236,-0.0427578713723399,0.0128777555391767,0.292530979876322
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32047,-0.00282373407270926,0.0157437245472569,-0.0336814341853328,0.0280339660399143,0.85766248615257
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32047,-0.0453941932201114,0.0203319173087194,-0.0852447511452014,-0.00554363529502138,0.0255985175167964
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32047,-0.00599187277803959,0.0061366707540883,-0.0180197474560527,0.00603600189997348,0.328892914677298
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",33852,-0.0128650379209006,0.00656671452410486,-0.0257357983881461,5.72254634494986e-06,0.0501255013419237
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",33852,0.00568906875692012,0.00532736993576403,-0.00475257631717738,0.0161307138310176,0.285593928028365
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",33852,-0.00509488951845069,0.00526398750743303,-0.0154123050330194,0.00522252599611804,0.333129505196181
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",33853,-0.00371573006934128,0.012665534206426,-0.0285401771139363,0.0211087169752537,0.769242893304783
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",33853,-0.00370169084430001,0.00827134480213528,-0.0199135266564852,0.0125101449678851,0.654500744577891
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",33853,-0.00189747759830948,0.0105355648021137,-0.0225471846104523,0.0187522294138333,0.857076047058932
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,47455,0.00935630703384138,0.012959900944917,-0.0160450988181958,0.0347577128858786,0.470336806747989
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,47455,0.0171707888558741,0.00837614189907853,0.00075355073368015,0.033588026978068,0.0403789775228368
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,47455,-0.00216758015802446,0.0257000322494808,-0.0525396433670069,0.048204483050958,0.932785605764888
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,47455,0.0125158735764593,0.00949089749803593,-0.00608628551969111,0.0311180326726097,0.187274225232838
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,47455,0.00925651296110463,0.0104741395713445,-0.0112728005987305,0.0297858265209398,0.376840593696114
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),47455,-0.00933650214931039,0.0113833673465177,-0.0316479021484851,0.0129748978498643,0.412117184487543
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,47455,-0.00441058301036738,0.00373479182259737,-0.0117307749826582,0.00290960896192346,0.237636553315816
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,27442,-0.0162960370905823,0.0125847874026255,-0.0409622203997283,0.00837014621856373,0.195438298617291
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,27442,-0.0230127038955142,0.0161305851374755,-0.0546286507649662,0.0086032429739378,0.153767875247052
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,27442,0.0103336517558617,0.0118803655362531,-0.0129518646951943,0.0336191682069177,0.384462940671402
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,27442,0.00124411120709058,0.0099332141776878,-0.0182249885811775,0.0207132109953587,0.900334565350368
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,47566,-0.00329253712169509,0.00399927063743087,-0.0111311075710596,0.00454603332766942,0.410354565338933
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,47566,-0.00716851580453835,0.0117157650186132,-0.0301314152410202,0.0157943836319435,0.540630166964832
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,47566,-0.00529062168701938,0.00403183177239476,-0.0131930119609131,0.00261176858687435,0.189461013802491
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,47566,0.00134659972794449,0.00392476031520312,-0.00634593048985362,0.0090391299457426,0.73152350117495
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,47566,0.00402871123421499,0.00569825452954527,-0.00713986764369373,0.0151972901121237,0.479568488901484
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,47566,0.000722958873120632,0.00580721514405042,-0.0106591828092182,0.0121051005554595,0.900925829197875
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,47566,0.00178960570152531,0.00432888380071619,-0.00669500654787842,0.0102742179509291,0.679309675786235
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,47566,-0.0059137270038124,0.0120325849618108,-0.0294975935289616,0.0176701395213368,0.623094356646028
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,39892,0.0050714119684053,0.00429643390404101,-0.00334959848351508,0.0134924224203257,0.23786779906132
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,39892,-0.0049640744709944,0.00451018994932689,-0.0138040467716751,0.0038758978296863,0.271071921119781
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,39892,-0.00338633224855101,0.00538223966886972,-0.0139355219995357,0.00716285750243363,0.529248128322136
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,39893,-0.00182277490142804,0.00737774134545018,-0.0162831479385104,0.0126375981356543,0.80486179302435
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,39893,-0.00662227989527814,0.00477945692626303,-0.0159900154707537,0.0027454556801974,0.165897021391731
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,47366,-0.00102379003101576,0.00442858733619811,-0.00970382120996404,0.00765624114793253,0.817178871618071
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,47366,0.00427735478829046,0.00348343211720486,-0.00255017216143107,0.011104881738012,0.21949157866008
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,47366,0.00669931578692774,0.00414758277230167,-0.00142994644678354,0.014828578020639,0.106273499530947
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,47366,-0.00318593092934232,0.00648468363326608,-0.0158959108505438,0.00952404899185919,0.623218227845573
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),47380,-0.00558560957623791,0.00381588930579331,-0.0130647526155928,0.00189353346311698,0.143268354809322
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,47380,0.00986283771721831,0.00528447953572826,-0.000494742172809081,0.0202204176072457,0.0620008976490431
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),47455,0.00524128850719364,0.00403189057876183,-0.00266121702717955,0.0131437940415668,0.193628055358736
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,47455,0.0121132365398708,0.0049968497716986,0.00231941098734153,0.0219070620924,0.0153506881882722
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,47455,-0.00308051545113629,0.00742328096160079,-0.0176301461358738,0.0114691152336013,0.67816008873314
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,47455,-0.000498057489292381,0.0088017384803432,-0.017749464910765,0.0167533499321803,0.954875256616939
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,47455,-0.00383808902276618,0.00848447527046859,-0.0204676605528846,0.0127914825073522,0.651009420318989
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,47455,-0.00408440557510464,0.012398791490771,-0.0283860368970158,0.0202172257468065,0.741841440058372
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37199,0.00111094518267628,0.00244235252860764,-0.00367606577339469,0.00589795613874725,0.649212441105857
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X864.Number of days or week walked 10+ minutes,47120,-0.0508997159944489,0.0452932664037657,-0.13967451814583,0.0378750861569319,0.261117509180042
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X874.Duration of walks,44041,-0.00298977877460216,0.00180917574625197,-0.00653576323725603,0.000556205688051702,0.098435178162666
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46489,0.0211292482541727,0.0439982756469301,-0.0651073720138103,0.107365868522156,0.631069205851002
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X894.Duration of moderate activity,41343,0.0486836688309669,0.0528996132015951,-0.0549995730441595,0.152366910706093,0.357427178903096
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X90087.No-wear time bias adjusted average acceleration,29063,0.00624099518292459,0.00376853151026705,-0.00114532657719882,0.013627316943048,0.0977656236041099
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46506,0.0810598368312746,0.0449399026074013,-0.00702237227923193,0.169142045941781,0.0712855833546108
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X914.Duration of vigorous activity,37171,0.00099823640400453,0.00238447868518719,-0.00367534181896236,0.00567181462697142,0.675486543269157
